_unit_id,_created_at,_canary,_id,_started_at,_channel,_trust,_worker_id,_country,_region,_city,_ip,direction,b1,b2,direction_gold,e1,e2,relation,relex_relcos,sent_id,sentence,term1,term2,twrex
504170003,7/17/2014 11:10:14,,1325168962,7/17/2014 11:10:05,instagc,0.6556,23149109,USA,NC,Durham,75.189.206.205,RELATED GENE (HERG) causes TORSADES DE POINTES,163,75,,181,94,causes,0.983869910099907,906446-FS1-4,Unintended inhibition of the cardiac potassium channel human ether a go go RELATED GENE (HERG) is considered the main culprit in drug induced arrhythmias known as TORSADES DE POINTES,TORSADES DE POINTES,RELATED GENE (HERG),RO-has_manifestation
504170003,7/17/2014 11:53:19,,1325202477,7/17/2014 11:52:59,instagc,0.6653,13763729,USA,"","",75.182.89.225,RELATED GENE (HERG) causes TORSADES DE POINTES,163,75,,181,94,causes,0.983869910099907,906446-FS1-4,Unintended inhibition of the cardiac potassium channel human ether a go go RELATED GENE (HERG) is considered the main culprit in drug induced arrhythmias known as TORSADES DE POINTES,TORSADES DE POINTES,RELATED GENE (HERG),RO-has_manifestation
504170003,7/17/2014 14:06:03,,1325316419,7/17/2014 14:05:38,neodev,0.5669,18339121,USA,SC,Sumter,173.93.188.194,RELATED GENE (HERG) causes TORSADES DE POINTES,163,75,,181,94,causes,0.983869910099907,906446-FS1-4,Unintended inhibition of the cardiac potassium channel human ether a go go RELATED GENE (HERG) is considered the main culprit in drug induced arrhythmias known as TORSADES DE POINTES,TORSADES DE POINTES,RELATED GENE (HERG),RO-has_manifestation
504170003,7/17/2014 14:31:56,,1325339901,7/17/2014 14:31:45,clixsense,0.4918,20614047,USA,MO,Maryville,174.32.162.147,RELATED GENE (HERG) causes TORSADES DE POINTES,163,75,,181,94,causes,0.983869910099907,906446-FS1-4,Unintended inhibition of the cardiac potassium channel human ether a go go RELATED GENE (HERG) is considered the main culprit in drug induced arrhythmias known as TORSADES DE POINTES,TORSADES DE POINTES,RELATED GENE (HERG),RO-has_manifestation
504170003,7/17/2014 15:05:34,,1325370260,7/17/2014 15:05:11,elite,0.534,28276268,USA,MI,Taylor,67.149.247.166,RELATED GENE (HERG) causes TORSADES DE POINTES,163,75,,181,94,causes,0.983869910099907,906446-FS1-4,Unintended inhibition of the cardiac potassium channel human ether a go go RELATED GENE (HERG) is considered the main culprit in drug induced arrhythmias known as TORSADES DE POINTES,TORSADES DE POINTES,RELATED GENE (HERG),RO-has_manifestation
504170003,7/17/2014 15:43:24,,1325404341,7/17/2014 15:43:06,prodege,0.4155,24403612,CAN,ON,Ajax,99.242.234.239,no_relation,163,75,,181,94,causes,0.983869910099907,906446-FS1-4,Unintended inhibition of the cardiac potassium channel human ether a go go RELATED GENE (HERG) is considered the main culprit in drug induced arrhythmias known as TORSADES DE POINTES,TORSADES DE POINTES,RELATED GENE (HERG),RO-has_manifestation
504170003,7/17/2014 15:48:27,,1325408512,7/17/2014 15:48:08,prodege,0.754,23541832,USA,AZ,Tempe,149.169.145.152,RELATED GENE (HERG) causes TORSADES DE POINTES,163,75,,181,94,causes,0.983869910099907,906446-FS1-4,Unintended inhibition of the cardiac potassium channel human ether a go go RELATED GENE (HERG) is considered the main culprit in drug induced arrhythmias known as TORSADES DE POINTES,TORSADES DE POINTES,RELATED GENE (HERG),RO-has_manifestation
504170004,7/17/2014 10:35:05,,1325142286,7/17/2014 10:34:58,clixsense,0.8472,19162475,GBR,M3,Frome,82.33.126.30,DENTAL FLUOROSIS diagnosed by FLUORIDE DEFICIENT AREAS,170,96,,193,112,diagnosed by,0.428571428571429,903698-FS1-13,"Recent studies indicate, however, that the prevalence and, to a lesser extent, the intensity of DENTAL FLUOROSIS have increased in schoolchildren in both fluoridated and FLUORIDE DEFICIENT AREAS.",FLUORIDE DEFICIENT AREAS,DENTAL FLUOROSIS,RO-has_causative_agent
504170004,7/17/2014 10:40:26,,1325146387,7/17/2014 10:40:07,clixsense,0.8958,19803139,NLD,06,Veldhoven,212.61.84.196,no_relation,170,96,,193,112,diagnosed by,0.428571428571429,903698-FS1-13,"Recent studies indicate, however, that the prevalence and, to a lesser extent, the intensity of DENTAL FLUOROSIS have increased in schoolchildren in both fluoridated and FLUORIDE DEFICIENT AREAS.",FLUORIDE DEFICIENT AREAS,DENTAL FLUOROSIS,RO-has_causative_agent
504170004,7/17/2014 11:13:17,,1325171682,7/17/2014 11:12:59,clixsense,0.8958,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,FLUORIDE DEFICIENT AREAS diagnosed by DENTAL FLUOROSIS,170,96,,193,112,diagnosed by,0.428571428571429,903698-FS1-13,"Recent studies indicate, however, that the prevalence and, to a lesser extent, the intensity of DENTAL FLUOROSIS have increased in schoolchildren in both fluoridated and FLUORIDE DEFICIENT AREAS.",FLUORIDE DEFICIENT AREAS,DENTAL FLUOROSIS,RO-has_causative_agent
504170004,7/17/2014 11:17:58,,1325175493,7/17/2014 11:17:16,prodege,0.6597,27934334,GBR,"","",86.130.153.15,no_relation,170,96,,193,112,diagnosed by,0.428571428571429,903698-FS1-13,"Recent studies indicate, however, that the prevalence and, to a lesser extent, the intensity of DENTAL FLUOROSIS have increased in schoolchildren in both fluoridated and FLUORIDE DEFICIENT AREAS.",FLUORIDE DEFICIENT AREAS,DENTAL FLUOROSIS,RO-has_causative_agent
504170004,7/17/2014 12:54:11,,1325249962,7/17/2014 12:53:54,clixsense,0.7,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,170,96,,193,112,diagnosed by,0.428571428571429,903698-FS1-13,"Recent studies indicate, however, that the prevalence and, to a lesser extent, the intensity of DENTAL FLUOROSIS have increased in schoolchildren in both fluoridated and FLUORIDE DEFICIENT AREAS.",FLUORIDE DEFICIENT AREAS,DENTAL FLUOROSIS,RO-has_causative_agent
504170004,7/17/2014 13:12:40,,1325265762,7/17/2014 13:12:15,neodev,0.7137,21515166,NLD,11,Nootdorp,83.86.58.179,FLUORIDE DEFICIENT AREAS diagnosed by DENTAL FLUOROSIS,170,96,,193,112,diagnosed by,0.428571428571429,903698-FS1-13,"Recent studies indicate, however, that the prevalence and, to a lesser extent, the intensity of DENTAL FLUOROSIS have increased in schoolchildren in both fluoridated and FLUORIDE DEFICIENT AREAS.",FLUORIDE DEFICIENT AREAS,DENTAL FLUOROSIS,RO-has_causative_agent
504170004,7/17/2014 13:38:34,,1325290687,7/17/2014 13:37:54,clixsense,0.6825,6574199,USA,TX,San Antonio,207.230.144.242,FLUORIDE DEFICIENT AREAS diagnosed by DENTAL FLUOROSIS,170,96,,193,112,diagnosed by,0.428571428571429,903698-FS1-13,"Recent studies indicate, however, that the prevalence and, to a lesser extent, the intensity of DENTAL FLUOROSIS have increased in schoolchildren in both fluoridated and FLUORIDE DEFICIENT AREAS.",FLUORIDE DEFICIENT AREAS,DENTAL FLUOROSIS,RO-has_causative_agent
504170005,7/17/2014 10:40:45,,1325146660,7/17/2014 10:40:27,clixsense,0.8958,19803139,NLD,06,Veldhoven,212.61.84.196,no_relation,56,95,,64,109,causes,0.408248290463863,902626-FS1-4,Localized amyloidosis of the bladder is a rare cause of HEMATURIA which is often confused with BLADDER CANCER,HEMATURIA,BLADDER CANCER,RO-disease_may_have_finding
504170005,7/17/2014 11:12:41,,1325171184,7/17/2014 11:12:17,clixsense,0.8958,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,no_relation,56,95,,64,109,causes,0.408248290463863,902626-FS1-4,Localized amyloidosis of the bladder is a rare cause of HEMATURIA which is often confused with BLADDER CANCER,HEMATURIA,BLADDER CANCER,RO-disease_may_have_finding
504170005,7/17/2014 11:17:15,,1325174910,7/17/2014 11:16:36,prodege,0.6597,27934334,GBR,"","",86.130.153.15,no_relation,56,95,,64,109,causes,0.408248290463863,902626-FS1-4,Localized amyloidosis of the bladder is a rare cause of HEMATURIA which is often confused with BLADDER CANCER,HEMATURIA,BLADDER CANCER,RO-disease_may_have_finding
504170005,7/17/2014 12:31:33,,1325231274,7/17/2014 12:31:13,prodege,0.6827,7664351,USA,NY,Cicero,74.111.0.21,no_relation,56,95,,64,109,causes,0.408248290463863,902626-FS1-4,Localized amyloidosis of the bladder is a rare cause of HEMATURIA which is often confused with BLADDER CANCER,HEMATURIA,BLADDER CANCER,RO-disease_may_have_finding
504170005,7/17/2014 13:25:14,,1325276592,7/17/2014 13:24:35,prodege,0.6909,24945126,GBR,F6,Romford,82.12.220.44,no_relation,56,95,,64,109,causes,0.408248290463863,902626-FS1-4,Localized amyloidosis of the bladder is a rare cause of HEMATURIA which is often confused with BLADDER CANCER,HEMATURIA,BLADDER CANCER,RO-disease_may_have_finding
504170005,7/17/2014 14:00:34,,1325311251,7/17/2014 14:00:17,clixsense,0.6744,6579377,CAN,BC,Richmond,174.6.142.227,no_relation,56,95,,64,109,causes,0.408248290463863,902626-FS1-4,Localized amyloidosis of the bladder is a rare cause of HEMATURIA which is often confused with BLADDER CANCER,HEMATURIA,BLADDER CANCER,RO-disease_may_have_finding
504170005,7/17/2014 14:05:12,,1325315723,7/17/2014 14:04:48,neodev,0.5669,18339121,USA,SC,Sumter,173.93.188.194,HEMATURIA causes BLADDER CANCER,56,95,,64,109,causes,0.408248290463863,902626-FS1-4,Localized amyloidosis of the bladder is a rare cause of HEMATURIA which is often confused with BLADDER CANCER,HEMATURIA,BLADDER CANCER,RO-disease_may_have_finding
504170006,7/17/2014 10:23:02,,1325132457,7/17/2014 10:22:55,clixsense,1.0,27793793,GBR,C5,Chester,151.230.27.155,INTERFERON THERAPY treats ADVANCED RENAL CELL CARCINOMA,92,69,,120,87,treats,0.966736489045664,907579-FS1-2,"Abdi EA, Nguyen GK, Ludwig RN et al. Pulmonary sarcoidosis following INTERFERON THERAPY for ADVANCED RENAL CELL CARCINOMA",ADVANCED RENAL CELL CARCINOMA,INTERFERON THERAPY,RO-may_treat
504170006,7/17/2014 10:35:13,,1325142466,7/17/2014 10:35:07,clixsense,0.8472,19162475,GBR,M3,Frome,82.33.126.30,ADVANCED RENAL CELL CARCINOMA treats INTERFERON THERAPY,92,69,,120,87,treats,0.966736489045664,907579-FS1-2,"Abdi EA, Nguyen GK, Ludwig RN et al. Pulmonary sarcoidosis following INTERFERON THERAPY for ADVANCED RENAL CELL CARCINOMA",ADVANCED RENAL CELL CARCINOMA,INTERFERON THERAPY,RO-may_treat
504170006,7/17/2014 11:19:07,,1325176289,7/17/2014 11:18:36,prodege,0.6597,27934334,GBR,"","",86.130.153.15,INTERFERON THERAPY treats ADVANCED RENAL CELL CARCINOMA,92,69,,120,87,treats,0.966736489045664,907579-FS1-2,"Abdi EA, Nguyen GK, Ludwig RN et al. Pulmonary sarcoidosis following INTERFERON THERAPY for ADVANCED RENAL CELL CARCINOMA",ADVANCED RENAL CELL CARCINOMA,INTERFERON THERAPY,RO-may_treat
504170006,7/17/2014 11:55:38,,1325203864,7/17/2014 11:55:04,tremorgames,0.7111,24449707,CAN,QC,Laval,96.21.249.72,INTERFERON THERAPY treats ADVANCED RENAL CELL CARCINOMA,92,69,,120,87,treats,0.966736489045664,907579-FS1-2,"Abdi EA, Nguyen GK, Ludwig RN et al. Pulmonary sarcoidosis following INTERFERON THERAPY for ADVANCED RENAL CELL CARCINOMA",ADVANCED RENAL CELL CARCINOMA,INTERFERON THERAPY,RO-may_treat
504170006,7/17/2014 13:24:34,,1325275936,7/17/2014 13:24:13,prodege,0.6909,24945126,GBR,F6,Romford,82.12.220.44,INTERFERON THERAPY treats ADVANCED RENAL CELL CARCINOMA,92,69,,120,87,treats,0.966736489045664,907579-FS1-2,"Abdi EA, Nguyen GK, Ludwig RN et al. Pulmonary sarcoidosis following INTERFERON THERAPY for ADVANCED RENAL CELL CARCINOMA",ADVANCED RENAL CELL CARCINOMA,INTERFERON THERAPY,RO-may_treat
504170006,7/17/2014 14:04:49,,1325315349,7/17/2014 14:04:29,clixsense,0.5901,15189335,GBR,T5,Aberdeen,90.218.222.164,INTERFERON THERAPY treats ADVANCED RENAL CELL CARCINOMA,92,69,,120,87,treats,0.966736489045664,907579-FS1-2,"Abdi EA, Nguyen GK, Ludwig RN et al. Pulmonary sarcoidosis following INTERFERON THERAPY for ADVANCED RENAL CELL CARCINOMA",ADVANCED RENAL CELL CARCINOMA,INTERFERON THERAPY,RO-may_treat
504170006,7/17/2014 14:09:38,,1325319501,7/17/2014 14:09:18,clixsense,0.7183,27871219,NLD,07,Amsterdam,87.210.207.223,INTERFERON THERAPY treats ADVANCED RENAL CELL CARCINOMA,92,69,,120,87,treats,0.966736489045664,907579-FS1-2,"Abdi EA, Nguyen GK, Ludwig RN et al. Pulmonary sarcoidosis following INTERFERON THERAPY for ADVANCED RENAL CELL CARCINOMA",ADVANCED RENAL CELL CARCINOMA,INTERFERON THERAPY,RO-may_treat
504170007,7/17/2014 10:23:12,,1325132555,7/17/2014 10:23:03,clixsense,1.0,27793793,GBR,C5,Chester,151.230.27.155,FACIAL ASYMMETRY causes FACIAL HEMIHYPERTROPHY,17,64,,32,86,causes,0.953462589245592,906208-FS1-4,All cases showed FACIAL ASYMMETRY one of them exhibiting marked FACIAL HEMIHYPERTROPHY,FACIAL ASYMMETRY,FACIAL HEMIHYPERTROPHY,RO-has_manifestation
504170007,7/17/2014 11:10:05,,1325168869,7/17/2014 11:09:57,instagc,0.6556,23149109,USA,NC,Durham,75.189.206.205,FACIAL HEMIHYPERTROPHY causes FACIAL ASYMMETRY,17,64,,32,86,causes,0.953462589245592,906208-FS1-4,All cases showed FACIAL ASYMMETRY one of them exhibiting marked FACIAL HEMIHYPERTROPHY,FACIAL ASYMMETRY,FACIAL HEMIHYPERTROPHY,RO-has_manifestation
504170007,7/17/2014 11:21:24,,1325177956,7/17/2014 11:21:10,prodege,0.6181,15439740,AUS,02,Jannali,27.96.208.89,no_relation,17,64,,32,86,causes,0.953462589245592,906208-FS1-4,All cases showed FACIAL ASYMMETRY one of them exhibiting marked FACIAL HEMIHYPERTROPHY,FACIAL ASYMMETRY,FACIAL HEMIHYPERTROPHY,RO-has_manifestation
504170007,7/17/2014 11:56:06,,1325204296,7/17/2014 11:55:38,tremorgames,0.7111,24449707,CAN,QC,Laval,96.21.249.72,no_relation,17,64,,32,86,causes,0.953462589245592,906208-FS1-4,All cases showed FACIAL ASYMMETRY one of them exhibiting marked FACIAL HEMIHYPERTROPHY,FACIAL ASYMMETRY,FACIAL HEMIHYPERTROPHY,RO-has_manifestation
504170007,7/17/2014 13:59:40,,1325310319,7/17/2014 13:59:27,clixsense,0.6744,6579377,CAN,BC,Richmond,174.6.142.227,no_relation,17,64,,32,86,causes,0.953462589245592,906208-FS1-4,All cases showed FACIAL ASYMMETRY one of them exhibiting marked FACIAL HEMIHYPERTROPHY,FACIAL ASYMMETRY,FACIAL HEMIHYPERTROPHY,RO-has_manifestation
504170007,7/17/2014 14:03:35,,1325314292,7/17/2014 14:03:26,clixsense,0.5901,15189335,GBR,T5,Aberdeen,90.218.222.164,FACIAL ASYMMETRY causes FACIAL HEMIHYPERTROPHY,17,64,,32,86,causes,0.953462589245592,906208-FS1-4,All cases showed FACIAL ASYMMETRY one of them exhibiting marked FACIAL HEMIHYPERTROPHY,FACIAL ASYMMETRY,FACIAL HEMIHYPERTROPHY,RO-has_manifestation
504170007,7/17/2014 14:10:45,,1325320395,7/17/2014 14:10:09,clixsense,0.7183,27871219,NLD,07,Amsterdam,87.210.207.223,no_relation,17,64,,32,86,causes,0.953462589245592,906208-FS1-4,All cases showed FACIAL ASYMMETRY one of them exhibiting marked FACIAL HEMIHYPERTROPHY,FACIAL ASYMMETRY,FACIAL HEMIHYPERTROPHY,RO-has_manifestation
504170008,7/17/2014 10:28:17,,1325136592,7/17/2014 10:28:02,instagc,0.9583,24252915,GBR,B7,Bristol,77.98.139.82,INSULIN SECRETAGOGUES treats TYPE 2 DIABETES,53,11,,67,32,treats,0.997458699830735,907897-FS1-2,The use of INSULIN SECRETAGOGUES in the treatment of TYPE 2 DIABETES,TYPE 2 DIABETES,INSULIN SECRETAGOGUES,RO-may_treat
504170008,7/17/2014 10:40:45,,1325146673,7/17/2014 10:40:27,clixsense,0.8958,19803139,NLD,06,Veldhoven,212.61.84.196,INSULIN SECRETAGOGUES treats TYPE 2 DIABETES,53,11,,67,32,treats,0.997458699830735,907897-FS1-2,The use of INSULIN SECRETAGOGUES in the treatment of TYPE 2 DIABETES,TYPE 2 DIABETES,INSULIN SECRETAGOGUES,RO-may_treat
504170008,7/17/2014 11:17:15,,1325174895,7/17/2014 11:16:36,prodege,0.6597,27934334,GBR,"","",86.130.153.15,INSULIN SECRETAGOGUES treats TYPE 2 DIABETES,53,11,,67,32,treats,0.997458699830735,907897-FS1-2,The use of INSULIN SECRETAGOGUES in the treatment of TYPE 2 DIABETES,TYPE 2 DIABETES,INSULIN SECRETAGOGUES,RO-may_treat
504170008,7/17/2014 11:28:18,,1325182757,7/17/2014 11:27:45,fusioncash,0.5583,7012325,USA,CT,Stamford,24.185.182.15,no_relation,53,11,,67,32,treats,0.997458699830735,907897-FS1-2,The use of INSULIN SECRETAGOGUES in the treatment of TYPE 2 DIABETES,TYPE 2 DIABETES,INSULIN SECRETAGOGUES,RO-may_treat
504170008,7/17/2014 11:54:51,,1325203397,7/17/2014 11:54:33,instagc,0.6653,13763729,USA,"","",75.182.89.225,INSULIN SECRETAGOGUES treats TYPE 2 DIABETES,53,11,,67,32,treats,0.997458699830735,907897-FS1-2,The use of INSULIN SECRETAGOGUES in the treatment of TYPE 2 DIABETES,TYPE 2 DIABETES,INSULIN SECRETAGOGUES,RO-may_treat
504170008,7/17/2014 12:54:37,,1325250274,7/17/2014 12:54:25,clixsense,0.7,16827630,GBR,A7,Birmingham,86.146.169.103,INSULIN SECRETAGOGUES treats TYPE 2 DIABETES,53,11,,67,32,treats,0.997458699830735,907897-FS1-2,The use of INSULIN SECRETAGOGUES in the treatment of TYPE 2 DIABETES,TYPE 2 DIABETES,INSULIN SECRETAGOGUES,RO-may_treat
504170008,7/17/2014 13:12:40,,1325265799,7/17/2014 13:12:15,neodev,0.7137,21515166,NLD,11,Nootdorp,83.86.58.179,INSULIN SECRETAGOGUES treats TYPE 2 DIABETES,53,11,,67,32,treats,0.997458699830735,907897-FS1-2,The use of INSULIN SECRETAGOGUES in the treatment of TYPE 2 DIABETES,TYPE 2 DIABETES,INSULIN SECRETAGOGUES,RO-may_treat
504170009,7/17/2014 10:27:05,,1325135436,7/17/2014 10:26:45,instagc,0.9583,24252915,GBR,B7,Bristol,77.98.139.82,THALIDOMIDE treats REFRACTORY MYELOMA,41,0,,58,11,treats,0.970142500145332,908083-FS1-2,THALIDOMIDE was used in 73 patients with REFRACTORY MYELOMA in 15 of 45 institutes participating in the Japan Myeloma Study Group.,REFRACTORY MYELOMA,THALIDOMIDE,RO-may_treat
504170009,7/17/2014 10:38:54,,1325145118,7/17/2014 10:38:36,clixsense,0.8958,19803139,NLD,06,Veldhoven,212.61.84.196,THALIDOMIDE treats REFRACTORY MYELOMA,41,0,,58,11,treats,0.970142500145332,908083-FS1-2,THALIDOMIDE was used in 73 patients with REFRACTORY MYELOMA in 15 of 45 institutes participating in the Japan Myeloma Study Group.,REFRACTORY MYELOMA,THALIDOMIDE,RO-may_treat
504170009,7/17/2014 10:45:38,,1325150449,7/17/2014 10:45:25,prodege,0.8333,9525153,CAN,ON,Toronto,65.95.92.180,THALIDOMIDE treats REFRACTORY MYELOMA,41,0,,58,11,treats,0.970142500145332,908083-FS1-2,THALIDOMIDE was used in 73 patients with REFRACTORY MYELOMA in 15 of 45 institutes participating in the Japan Myeloma Study Group.,REFRACTORY MYELOMA,THALIDOMIDE,RO-may_treat
504170009,7/17/2014 11:22:30,,1325178805,7/17/2014 11:22:16,prodege,0.6181,15439740,AUS,02,Jannali,27.96.208.89,THALIDOMIDE treats REFRACTORY MYELOMA,41,0,,58,11,treats,0.970142500145332,908083-FS1-2,THALIDOMIDE was used in 73 patients with REFRACTORY MYELOMA in 15 of 45 institutes participating in the Japan Myeloma Study Group.,REFRACTORY MYELOMA,THALIDOMIDE,RO-may_treat
504170009,7/17/2014 11:26:16,,1325181369,7/17/2014 11:25:40,fusioncash,0.5583,7012325,USA,CT,Stamford,24.185.182.15,THALIDOMIDE treats REFRACTORY MYELOMA,41,0,,58,11,treats,0.970142500145332,908083-FS1-2,THALIDOMIDE was used in 73 patients with REFRACTORY MYELOMA in 15 of 45 institutes participating in the Japan Myeloma Study Group.,REFRACTORY MYELOMA,THALIDOMIDE,RO-may_treat
504170009,7/17/2014 11:51:57,,1325201409,7/17/2014 11:51:40,gifthulk,0.8375,21916793,GBR,"","",87.115.178.12,THALIDOMIDE treats REFRACTORY MYELOMA,41,0,,58,11,treats,0.970142500145332,908083-FS1-2,THALIDOMIDE was used in 73 patients with REFRACTORY MYELOMA in 15 of 45 institutes participating in the Japan Myeloma Study Group.,REFRACTORY MYELOMA,THALIDOMIDE,RO-may_treat
504170009,7/17/2014 13:25:49,,1325277088,7/17/2014 13:25:16,prodege,0.6909,24945126,GBR,F6,Romford,82.12.220.44,THALIDOMIDE treats REFRACTORY MYELOMA,41,0,,58,11,treats,0.970142500145332,908083-FS1-2,THALIDOMIDE was used in 73 patients with REFRACTORY MYELOMA in 15 of 45 institutes participating in the Japan Myeloma Study Group.,REFRACTORY MYELOMA,THALIDOMIDE,RO-may_treat
504170010,7/17/2014 11:54:11,,1325203035,7/17/2014 11:54:01,gifthulk,0.8375,21916793,GBR,"","",87.115.178.12,AMANTADINE treats PARKINSON'S DISEASE,31,0,,49,10,treats,1,907950-FS1-2,AMANTADINE in the treatment of PARKINSON'S DISEASE,PARKINSON'S DISEASE,AMANTADINE,RO-may_treat
504170010,7/17/2014 12:16:10,,1325219182,7/17/2014 12:15:52,elite,0.6262,28503042,USA,NJ,Woodbridge,54.191.150.115,AMANTADINE treats PARKINSON'S DISEASE,31,0,,49,10,treats,1,907950-FS1-2,AMANTADINE in the treatment of PARKINSON'S DISEASE,PARKINSON'S DISEASE,AMANTADINE,RO-may_treat
504170010,7/17/2014 13:23:50,,1325275236,7/17/2014 13:23:32,prodege,0.6909,24945126,GBR,F6,Romford,82.12.220.44,AMANTADINE treats PARKINSON'S DISEASE,31,0,,49,10,treats,1,907950-FS1-2,AMANTADINE in the treatment of PARKINSON'S DISEASE,PARKINSON'S DISEASE,AMANTADINE,RO-may_treat
504170010,7/17/2014 13:38:57,,1325291105,7/17/2014 13:38:39,clixsense,0.6825,6574199,USA,TX,San Antonio,207.230.144.242,AMANTADINE treats PARKINSON'S DISEASE,31,0,,49,10,treats,1,907950-FS1-2,AMANTADINE in the treatment of PARKINSON'S DISEASE,PARKINSON'S DISEASE,AMANTADINE,RO-may_treat
504170010,7/17/2014 13:59:40,,1325310307,7/17/2014 13:59:27,clixsense,0.6744,6579377,CAN,BC,Richmond,174.6.142.227,AMANTADINE treats PARKINSON'S DISEASE,31,0,,49,10,treats,1,907950-FS1-2,AMANTADINE in the treatment of PARKINSON'S DISEASE,PARKINSON'S DISEASE,AMANTADINE,RO-may_treat
504170010,7/17/2014 14:11:22,,1325321065,7/17/2014 14:11:06,clixsense,0.7183,27871219,NLD,07,Amsterdam,87.210.207.223,AMANTADINE treats PARKINSON'S DISEASE,31,0,,49,10,treats,1,907950-FS1-2,AMANTADINE in the treatment of PARKINSON'S DISEASE,PARKINSON'S DISEASE,AMANTADINE,RO-may_treat
504170010,7/17/2014 14:32:50,,1325340649,7/17/2014 14:32:42,clixsense,0.4918,20614047,USA,MO,Maryville,174.32.162.147,PARKINSON'S DISEASE treats AMANTADINE,31,0,,49,10,treats,1,907950-FS1-2,AMANTADINE in the treatment of PARKINSON'S DISEASE,PARKINSON'S DISEASE,AMANTADINE,RO-may_treat
504170011,7/17/2014 10:39:46,,1325145871,7/17/2014 10:39:25,clixsense,0.8958,19803139,NLD,06,Veldhoven,212.61.84.196,PATELLO FEMORAL JOINT is location of ARTHROSIS OF THE KNEE,44,109,,64,130,is location of,0.900070320740819,902308-FS1-9,The progressive radiological changes in the PATELLO FEMORAL JOINT after upper tibial osteotomy performed for ARTHROSIS OF THE KNEE were studied more than 10 years after the surgical procedure.,PATELLO FEMORAL JOINT,ARTHROSIS OF THE KNEE,RO-disease_has_primary_anatomic_site
504170011,7/17/2014 10:46:39,,1325151220,7/17/2014 10:46:14,prodege,0.8333,9525153,CAN,ON,Toronto,65.95.92.180,ARTHROSIS OF THE KNEE is location of PATELLO FEMORAL JOINT,44,109,,64,130,is location of,0.900070320740819,902308-FS1-9,The progressive radiological changes in the PATELLO FEMORAL JOINT after upper tibial osteotomy performed for ARTHROSIS OF THE KNEE were studied more than 10 years after the surgical procedure.,PATELLO FEMORAL JOINT,ARTHROSIS OF THE KNEE,RO-disease_has_primary_anatomic_site
504170011,7/17/2014 11:26:16,,1325181371,7/17/2014 11:25:40,fusioncash,0.5583,7012325,USA,CT,Stamford,24.185.182.15,no_relation,44,109,,64,130,is location of,0.900070320740819,902308-FS1-9,The progressive radiological changes in the PATELLO FEMORAL JOINT after upper tibial osteotomy performed for ARTHROSIS OF THE KNEE were studied more than 10 years after the surgical procedure.,PATELLO FEMORAL JOINT,ARTHROSIS OF THE KNEE,RO-disease_has_primary_anatomic_site
504170011,7/17/2014 12:15:27,,1325218494,7/17/2014 12:15:09,elite,0.6262,28503042,USA,NJ,Woodbridge,54.191.150.115,PATELLO FEMORAL JOINT is location of ARTHROSIS OF THE KNEE,44,109,,64,130,is location of,0.900070320740819,902308-FS1-9,The progressive radiological changes in the PATELLO FEMORAL JOINT after upper tibial osteotomy performed for ARTHROSIS OF THE KNEE were studied more than 10 years after the surgical procedure.,PATELLO FEMORAL JOINT,ARTHROSIS OF THE KNEE,RO-disease_has_primary_anatomic_site
504170011,7/17/2014 13:23:50,,1325275237,7/17/2014 13:23:32,prodege,0.6909,24945126,GBR,F6,Romford,82.12.220.44,PATELLO FEMORAL JOINT is location of ARTHROSIS OF THE KNEE,44,109,,64,130,is location of,0.900070320740819,902308-FS1-9,The progressive radiological changes in the PATELLO FEMORAL JOINT after upper tibial osteotomy performed for ARTHROSIS OF THE KNEE were studied more than 10 years after the surgical procedure.,PATELLO FEMORAL JOINT,ARTHROSIS OF THE KNEE,RO-disease_has_primary_anatomic_site
504170011,7/17/2014 14:32:24,,1325340353,7/17/2014 14:32:13,clixsense,0.4918,20614047,USA,MO,Maryville,174.32.162.147,no_relation,44,109,,64,130,is location of,0.900070320740819,902308-FS1-9,The progressive radiological changes in the PATELLO FEMORAL JOINT after upper tibial osteotomy performed for ARTHROSIS OF THE KNEE were studied more than 10 years after the surgical procedure.,PATELLO FEMORAL JOINT,ARTHROSIS OF THE KNEE,RO-disease_has_primary_anatomic_site
504170011,7/17/2014 15:05:04,,1325369662,7/17/2014 15:04:41,elite,0.534,28276268,USA,MI,Taylor,67.149.247.166,PATELLO FEMORAL JOINT is location of ARTHROSIS OF THE KNEE,44,109,,64,130,is location of,0.900070320740819,902308-FS1-9,The progressive radiological changes in the PATELLO FEMORAL JOINT after upper tibial osteotomy performed for ARTHROSIS OF THE KNEE were studied more than 10 years after the surgical procedure.,PATELLO FEMORAL JOINT,ARTHROSIS OF THE KNEE,RO-disease_has_primary_anatomic_site
504170012,7/17/2014 10:27:22,,1325135613,7/17/2014 10:27:06,instagc,0.9583,24252915,GBR,B7,Bristol,77.98.139.82,PHEOCHROMOCYTOMA diagnosed by PHENTOLAMINE,106,84,,121,96,diagnosed by,0.615457454896664,906704-FS1-13,"177 ,   a  Sudden and marked reduction in BP following parenteral administration of PHENTOLAMINE suggests PHEOCHROMOCYTOMA;  a   however, false negative and false positive responses are frequent.",PHEOCHROMOCYTOMA,PHENTOLAMINE,RO-may_diagnose
504170012,7/17/2014 10:39:24,,1325145538,7/17/2014 10:38:56,clixsense,0.8958,19803139,NLD,06,Veldhoven,212.61.84.196,PHEOCHROMOCYTOMA diagnosed by PHENTOLAMINE,106,84,,121,96,diagnosed by,0.615457454896664,906704-FS1-13,"177 ,   a  Sudden and marked reduction in BP following parenteral administration of PHENTOLAMINE suggests PHEOCHROMOCYTOMA;  a   however, false negative and false positive responses are frequent.",PHEOCHROMOCYTOMA,PHENTOLAMINE,RO-may_diagnose
504170012,7/17/2014 11:10:14,,1325168973,7/17/2014 11:10:05,instagc,0.6556,23149109,USA,NC,Durham,75.189.206.205,PHENTOLAMINE diagnosed by PHEOCHROMOCYTOMA,106,84,,121,96,diagnosed by,0.615457454896664,906704-FS1-13,"177 ,   a  Sudden and marked reduction in BP following parenteral administration of PHENTOLAMINE suggests PHEOCHROMOCYTOMA;  a   however, false negative and false positive responses are frequent.",PHEOCHROMOCYTOMA,PHENTOLAMINE,RO-may_diagnose
504170012,7/17/2014 11:12:41,,1325171198,7/17/2014 11:12:17,clixsense,0.8958,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,PHEOCHROMOCYTOMA diagnosed by PHENTOLAMINE,106,84,,121,96,diagnosed by,0.615457454896664,906704-FS1-13,"177 ,   a  Sudden and marked reduction in BP following parenteral administration of PHENTOLAMINE suggests PHEOCHROMOCYTOMA;  a   however, false negative and false positive responses are frequent.",PHEOCHROMOCYTOMA,PHENTOLAMINE,RO-may_diagnose
504170012,7/17/2014 13:25:49,,1325277092,7/17/2014 13:25:16,prodege,0.6909,24945126,GBR,F6,Romford,82.12.220.44,no_relation,106,84,,121,96,diagnosed by,0.615457454896664,906704-FS1-13,"177 ,   a  Sudden and marked reduction in BP following parenteral administration of PHENTOLAMINE suggests PHEOCHROMOCYTOMA;  a   however, false negative and false positive responses are frequent.",PHEOCHROMOCYTOMA,PHENTOLAMINE,RO-may_diagnose
504170012,7/17/2014 13:37:53,,1325290043,7/17/2014 13:37:35,clixsense,0.6825,6574199,USA,TX,San Antonio,207.230.144.242,PHENTOLAMINE diagnosed by PHEOCHROMOCYTOMA,106,84,,121,96,diagnosed by,0.615457454896664,906704-FS1-13,"177 ,   a  Sudden and marked reduction in BP following parenteral administration of PHENTOLAMINE suggests PHEOCHROMOCYTOMA;  a   however, false negative and false positive responses are frequent.",PHEOCHROMOCYTOMA,PHENTOLAMINE,RO-may_diagnose
504170012,7/17/2014 14:01:11,,1325311902,7/17/2014 14:00:35,clixsense,0.6744,6579377,CAN,BC,Richmond,174.6.142.227,PHEOCHROMOCYTOMA diagnosed by PHENTOLAMINE,106,84,,121,96,diagnosed by,0.615457454896664,906704-FS1-13,"177 ,   a  Sudden and marked reduction in BP following parenteral administration of PHENTOLAMINE suggests PHEOCHROMOCYTOMA;  a   however, false negative and false positive responses are frequent.",PHEOCHROMOCYTOMA,PHENTOLAMINE,RO-may_diagnose
504170013,7/17/2014 10:46:14,,1325150876,7/17/2014 10:45:39,prodege,0.8333,9525153,CAN,ON,Toronto,65.95.92.180,NEUROENDOCRINE DIFFERENTIATION diagnosed by LARGE CELL TYPE NEUROENDOCRINE TUMORS,298,203,,327,240,diagnosed by,0.356034497458156,901838-FS1-13,KTA7 was considered to be derived from large cell undifferentiated carcinoma with neuroendocrine differentiation (large cell neuroendocrine tumor) and thus may fine use in studies on the pathobiology of LARGE CELL TYPE NEUROENDOCRINE TUMORS since it expresses at the same time marker substances of NEUROENDOCRINE DIFFERENTIATION and the hCG alpha subunit.,NEUROENDOCRINE DIFFERENTIATION,LARGE CELL TYPE NEUROENDOCRINE TUMORS,RO-disease_has_finding
504170013,7/17/2014 11:57:55,,1325205405,7/17/2014 11:57:28,tremorgames,0.7111,24449707,CAN,QC,Laval,96.21.249.72,no_relation,298,203,,327,240,diagnosed by,0.356034497458156,901838-FS1-13,KTA7 was considered to be derived from large cell undifferentiated carcinoma with neuroendocrine differentiation (large cell neuroendocrine tumor) and thus may fine use in studies on the pathobiology of LARGE CELL TYPE NEUROENDOCRINE TUMORS since it expresses at the same time marker substances of NEUROENDOCRINE DIFFERENTIATION and the hCG alpha subunit.,NEUROENDOCRINE DIFFERENTIATION,LARGE CELL TYPE NEUROENDOCRINE TUMORS,RO-disease_has_finding
504170013,7/17/2014 12:15:07,,1325218273,7/17/2014 12:14:51,elite,0.6262,28503042,USA,NJ,Woodbridge,54.191.150.115,LARGE CELL TYPE NEUROENDOCRINE TUMORS diagnosed by NEUROENDOCRINE DIFFERENTIATION,298,203,,327,240,diagnosed by,0.356034497458156,901838-FS1-13,KTA7 was considered to be derived from large cell undifferentiated carcinoma with neuroendocrine differentiation (large cell neuroendocrine tumor) and thus may fine use in studies on the pathobiology of LARGE CELL TYPE NEUROENDOCRINE TUMORS since it expresses at the same time marker substances of NEUROENDOCRINE DIFFERENTIATION and the hCG alpha subunit.,NEUROENDOCRINE DIFFERENTIATION,LARGE CELL TYPE NEUROENDOCRINE TUMORS,RO-disease_has_finding
504170013,7/17/2014 12:32:40,,1325232080,7/17/2014 12:32:10,prodege,0.6827,7664351,USA,NY,Cicero,74.111.0.21,LARGE CELL TYPE NEUROENDOCRINE TUMORS diagnosed by NEUROENDOCRINE DIFFERENTIATION,298,203,,327,240,diagnosed by,0.356034497458156,901838-FS1-13,KTA7 was considered to be derived from large cell undifferentiated carcinoma with neuroendocrine differentiation (large cell neuroendocrine tumor) and thus may fine use in studies on the pathobiology of LARGE CELL TYPE NEUROENDOCRINE TUMORS since it expresses at the same time marker substances of NEUROENDOCRINE DIFFERENTIATION and the hCG alpha subunit.,NEUROENDOCRINE DIFFERENTIATION,LARGE CELL TYPE NEUROENDOCRINE TUMORS,RO-disease_has_finding
504170013,7/17/2014 13:12:14,,1325265406,7/17/2014 13:11:33,neodev,0.7137,21515166,NLD,11,Nootdorp,83.86.58.179,NEUROENDOCRINE DIFFERENTIATION diagnosed by LARGE CELL TYPE NEUROENDOCRINE TUMORS,298,203,,327,240,diagnosed by,0.356034497458156,901838-FS1-13,KTA7 was considered to be derived from large cell undifferentiated carcinoma with neuroendocrine differentiation (large cell neuroendocrine tumor) and thus may fine use in studies on the pathobiology of LARGE CELL TYPE NEUROENDOCRINE TUMORS since it expresses at the same time marker substances of NEUROENDOCRINE DIFFERENTIATION and the hCG alpha subunit.,NEUROENDOCRINE DIFFERENTIATION,LARGE CELL TYPE NEUROENDOCRINE TUMORS,RO-disease_has_finding
504170013,7/17/2014 13:59:26,,1325310063,7/17/2014 13:58:51,clixsense,0.6744,6579377,CAN,BC,Richmond,174.6.142.227,LARGE CELL TYPE NEUROENDOCRINE TUMORS diagnosed by NEUROENDOCRINE DIFFERENTIATION,298,203,,327,240,diagnosed by,0.356034497458156,901838-FS1-13,KTA7 was considered to be derived from large cell undifferentiated carcinoma with neuroendocrine differentiation (large cell neuroendocrine tumor) and thus may fine use in studies on the pathobiology of LARGE CELL TYPE NEUROENDOCRINE TUMORS since it expresses at the same time marker substances of NEUROENDOCRINE DIFFERENTIATION and the hCG alpha subunit.,NEUROENDOCRINE DIFFERENTIATION,LARGE CELL TYPE NEUROENDOCRINE TUMORS,RO-disease_has_finding
504170013,7/17/2014 14:03:35,,1325314294,7/17/2014 14:03:26,clixsense,0.5901,15189335,GBR,T5,Aberdeen,90.218.222.164,NEUROENDOCRINE DIFFERENTIATION diagnosed by LARGE CELL TYPE NEUROENDOCRINE TUMORS,298,203,,327,240,diagnosed by,0.356034497458156,901838-FS1-13,KTA7 was considered to be derived from large cell undifferentiated carcinoma with neuroendocrine differentiation (large cell neuroendocrine tumor) and thus may fine use in studies on the pathobiology of LARGE CELL TYPE NEUROENDOCRINE TUMORS since it expresses at the same time marker substances of NEUROENDOCRINE DIFFERENTIATION and the hCG alpha subunit.,NEUROENDOCRINE DIFFERENTIATION,LARGE CELL TYPE NEUROENDOCRINE TUMORS,RO-disease_has_finding
504170014,7/17/2014 11:28:18,,1325182756,7/17/2014 11:27:45,fusioncash,0.5583,7012325,USA,CT,Stamford,24.185.182.15,HYDROXYUREA treats POLYCYTHEMIA VERA,32,0,,48,11,treats,0.986393923832143,907569-FS1-2,HYDROXYUREA in the treatment of POLYCYTHEMIA VERA: a prospective study of 100 patients over a 20 year period.,POLYCYTHEMIA VERA,HYDROXYUREA,RO-may_treat
504170014,7/17/2014 11:52:58,,1325202193,7/17/2014 11:52:46,instagc,0.6653,13763729,USA,"","",75.182.89.225,HYDROXYUREA treats POLYCYTHEMIA VERA,32,0,,48,11,treats,0.986393923832143,907569-FS1-2,HYDROXYUREA in the treatment of POLYCYTHEMIA VERA: a prospective study of 100 patients over a 20 year period.,POLYCYTHEMIA VERA,HYDROXYUREA,RO-may_treat
504170014,7/17/2014 12:14:13,,1325217527,7/17/2014 12:13:57,elite,0.6262,28503042,USA,NJ,Woodbridge,54.191.150.115,HYDROXYUREA treats POLYCYTHEMIA VERA,32,0,,48,11,treats,0.986393923832143,907569-FS1-2,HYDROXYUREA in the treatment of POLYCYTHEMIA VERA: a prospective study of 100 patients over a 20 year period.,POLYCYTHEMIA VERA,HYDROXYUREA,RO-may_treat
504170014,7/17/2014 12:54:23,,1325250086,7/17/2014 12:54:12,clixsense,0.7,16827630,GBR,A7,Birmingham,86.146.169.103,HYDROXYUREA treats POLYCYTHEMIA VERA,32,0,,48,11,treats,0.986393923832143,907569-FS1-2,HYDROXYUREA in the treatment of POLYCYTHEMIA VERA: a prospective study of 100 patients over a 20 year period.,POLYCYTHEMIA VERA,HYDROXYUREA,RO-may_treat
504170014,7/17/2014 14:04:28,,1325315004,7/17/2014 14:04:08,clixsense,0.5901,15189335,GBR,T5,Aberdeen,90.218.222.164,HYDROXYUREA treats POLYCYTHEMIA VERA,32,0,,48,11,treats,0.986393923832143,907569-FS1-2,HYDROXYUREA in the treatment of POLYCYTHEMIA VERA: a prospective study of 100 patients over a 20 year period.,POLYCYTHEMIA VERA,HYDROXYUREA,RO-may_treat
504170014,7/17/2014 14:32:38,,1325340480,7/17/2014 14:32:27,clixsense,0.4918,20614047,USA,MO,Maryville,174.32.162.147,POLYCYTHEMIA VERA treats HYDROXYUREA,32,0,,48,11,treats,0.986393923832143,907569-FS1-2,HYDROXYUREA in the treatment of POLYCYTHEMIA VERA: a prospective study of 100 patients over a 20 year period.,POLYCYTHEMIA VERA,HYDROXYUREA,RO-may_treat
504170014,7/17/2014 14:47:10,,1325353207,7/17/2014 14:46:08,clixsense,0.2,11764504,GBR,M5,Southend-on-sea,92.232.81.238,no_relation,32,0,,48,11,treats,0.986393923832143,907569-FS1-2,HYDROXYUREA in the treatment of POLYCYTHEMIA VERA: a prospective study of 100 patients over a 20 year period.,POLYCYTHEMIA VERA,HYDROXYUREA,RO-may_treat
504170015,7/17/2014 10:35:21,,1325142604,7/17/2014 10:35:15,clixsense,0.8472,19162475,GBR,M3,Frome,82.33.126.30,CRANIAL NERVES is location of NEURO OPHTHALMOLOGIC AND CRANIAL NERVE DISORDERS,95,116,,108,164,is location of,0.918558653543692,902415-FS1-9,PERIPHERAL NERVOUS SYSTEM DISORDERS  INTRODUCTION  The peripheral nervous system refers to the CRANIAL NERVES (see  NEURO OPHTHALMOLOGIC AND CRANIAL NERVE DISORDERS and spinal nerves from their origin to their end.,CRANIAL NERVES,NEURO OPHTHALMOLOGIC AND CRANIAL NERVE DISORDERS,RO-disease_has_primary_anatomic_site
504170015,7/17/2014 10:40:26,,1325146388,7/17/2014 10:40:07,clixsense,0.8958,19803139,NLD,06,Veldhoven,212.61.84.196,CRANIAL NERVES is location of NEURO OPHTHALMOLOGIC AND CRANIAL NERVE DISORDERS,95,116,,108,164,is location of,0.918558653543692,902415-FS1-9,PERIPHERAL NERVOUS SYSTEM DISORDERS  INTRODUCTION  The peripheral nervous system refers to the CRANIAL NERVES (see  NEURO OPHTHALMOLOGIC AND CRANIAL NERVE DISORDERS and spinal nerves from their origin to their end.,CRANIAL NERVES,NEURO OPHTHALMOLOGIC AND CRANIAL NERVE DISORDERS,RO-disease_has_primary_anatomic_site
504170015,7/17/2014 11:27:44,,1325182357,7/17/2014 11:27:17,fusioncash,0.5583,7012325,USA,CT,Stamford,24.185.182.15,no_relation,95,116,,108,164,is location of,0.918558653543692,902415-FS1-9,PERIPHERAL NERVOUS SYSTEM DISORDERS  INTRODUCTION  The peripheral nervous system refers to the CRANIAL NERVES (see  NEURO OPHTHALMOLOGIC AND CRANIAL NERVE DISORDERS and spinal nerves from their origin to their end.,CRANIAL NERVES,NEURO OPHTHALMOLOGIC AND CRANIAL NERVE DISORDERS,RO-disease_has_primary_anatomic_site
504170015,7/17/2014 11:57:27,,1325205051,7/17/2014 11:56:54,tremorgames,0.7111,24449707,CAN,QC,Laval,96.21.249.72,CRANIAL NERVES is location of NEURO OPHTHALMOLOGIC AND CRANIAL NERVE DISORDERS,95,116,,108,164,is location of,0.918558653543692,902415-FS1-9,PERIPHERAL NERVOUS SYSTEM DISORDERS  INTRODUCTION  The peripheral nervous system refers to the CRANIAL NERVES (see  NEURO OPHTHALMOLOGIC AND CRANIAL NERVE DISORDERS and spinal nerves from their origin to their end.,CRANIAL NERVES,NEURO OPHTHALMOLOGIC AND CRANIAL NERVE DISORDERS,RO-disease_has_primary_anatomic_site
504170015,7/17/2014 12:30:28,,1325230215,7/17/2014 12:29:58,prodege,0.6827,7664351,USA,NY,Cicero,74.111.0.21,CRANIAL NERVES is location of NEURO OPHTHALMOLOGIC AND CRANIAL NERVE DISORDERS,95,116,,108,164,is location of,0.918558653543692,902415-FS1-9,PERIPHERAL NERVOUS SYSTEM DISORDERS  INTRODUCTION  The peripheral nervous system refers to the CRANIAL NERVES (see  NEURO OPHTHALMOLOGIC AND CRANIAL NERVE DISORDERS and spinal nerves from their origin to their end.,CRANIAL NERVES,NEURO OPHTHALMOLOGIC AND CRANIAL NERVE DISORDERS,RO-disease_has_primary_anatomic_site
504170015,7/17/2014 13:38:39,,1325290756,7/17/2014 13:38:04,prodege,0.5202,28039757,GBR,L8,Southport,109.155.158.54,no_relation,95,116,,108,164,is location of,0.918558653543692,902415-FS1-9,PERIPHERAL NERVOUS SYSTEM DISORDERS  INTRODUCTION  The peripheral nervous system refers to the CRANIAL NERVES (see  NEURO OPHTHALMOLOGIC AND CRANIAL NERVE DISORDERS and spinal nerves from their origin to their end.,CRANIAL NERVES,NEURO OPHTHALMOLOGIC AND CRANIAL NERVE DISORDERS,RO-disease_has_primary_anatomic_site
504170015,7/17/2014 13:39:24,,1325291547,7/17/2014 13:38:58,clixsense,0.6825,6574199,USA,TX,San Antonio,207.230.144.242,CRANIAL NERVES is location of NEURO OPHTHALMOLOGIC AND CRANIAL NERVE DISORDERS,95,116,,108,164,is location of,0.918558653543692,902415-FS1-9,PERIPHERAL NERVOUS SYSTEM DISORDERS  INTRODUCTION  The peripheral nervous system refers to the CRANIAL NERVES (see  NEURO OPHTHALMOLOGIC AND CRANIAL NERVE DISORDERS and spinal nerves from their origin to their end.,CRANIAL NERVES,NEURO OPHTHALMOLOGIC AND CRANIAL NERVE DISORDERS,RO-disease_has_primary_anatomic_site
504170016,7/17/2014 10:45:24,,1325150223,7/17/2014 10:45:02,prodege,0.8333,9525153,CAN,ON,Toronto,65.95.92.180,NEUROENDOCRINE DIFFERENTIATION causes LARGE CELL TYPE NEUROENDOCRINE TUMORS,298,203,,327,240,causes,0.356034497458156,901838-FS1-4,KTA7 was considered to be derived from large cell undifferentiated carcinoma with neuroendocrine differentiation (large cell neuroendocrine tumor) and thus may fine use in studies on the pathobiology of LARGE CELL TYPE NEUROENDOCRINE TUMORS since it expresses at the same time marker substances of NEUROENDOCRINE DIFFERENTIATION and the hCG alpha subunit.,NEUROENDOCRINE DIFFERENTIATION,LARGE CELL TYPE NEUROENDOCRINE TUMORS,RO-disease_has_finding
504170016,7/17/2014 11:12:16,,1325170839,7/17/2014 11:11:52,clixsense,0.8958,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,NEUROENDOCRINE DIFFERENTIATION causes LARGE CELL TYPE NEUROENDOCRINE TUMORS,298,203,,327,240,causes,0.356034497458156,901838-FS1-4,KTA7 was considered to be derived from large cell undifferentiated carcinoma with neuroendocrine differentiation (large cell neuroendocrine tumor) and thus may fine use in studies on the pathobiology of LARGE CELL TYPE NEUROENDOCRINE TUMORS since it expresses at the same time marker substances of NEUROENDOCRINE DIFFERENTIATION and the hCG alpha subunit.,NEUROENDOCRINE DIFFERENTIATION,LARGE CELL TYPE NEUROENDOCRINE TUMORS,RO-disease_has_finding
504170016,7/17/2014 11:21:08,,1325177700,7/17/2014 11:20:47,prodege,0.6181,15439740,AUS,02,Jannali,27.96.208.89,no_relation,298,203,,327,240,causes,0.356034497458156,901838-FS1-4,KTA7 was considered to be derived from large cell undifferentiated carcinoma with neuroendocrine differentiation (large cell neuroendocrine tumor) and thus may fine use in studies on the pathobiology of LARGE CELL TYPE NEUROENDOCRINE TUMORS since it expresses at the same time marker substances of NEUROENDOCRINE DIFFERENTIATION and the hCG alpha subunit.,NEUROENDOCRINE DIFFERENTIATION,LARGE CELL TYPE NEUROENDOCRINE TUMORS,RO-disease_has_finding
504170016,7/17/2014 11:53:59,,1325202877,7/17/2014 11:53:36,instagc,0.6653,13763729,USA,"","",75.182.89.225,no_relation,298,203,,327,240,causes,0.356034497458156,901838-FS1-4,KTA7 was considered to be derived from large cell undifferentiated carcinoma with neuroendocrine differentiation (large cell neuroendocrine tumor) and thus may fine use in studies on the pathobiology of LARGE CELL TYPE NEUROENDOCRINE TUMORS since it expresses at the same time marker substances of NEUROENDOCRINE DIFFERENTIATION and the hCG alpha subunit.,NEUROENDOCRINE DIFFERENTIATION,LARGE CELL TYPE NEUROENDOCRINE TUMORS,RO-disease_has_finding
504170016,7/17/2014 11:56:53,,1325204664,7/17/2014 11:56:28,tremorgames,0.7111,24449707,CAN,QC,Laval,96.21.249.72,no_relation,298,203,,327,240,causes,0.356034497458156,901838-FS1-4,KTA7 was considered to be derived from large cell undifferentiated carcinoma with neuroendocrine differentiation (large cell neuroendocrine tumor) and thus may fine use in studies on the pathobiology of LARGE CELL TYPE NEUROENDOCRINE TUMORS since it expresses at the same time marker substances of NEUROENDOCRINE DIFFERENTIATION and the hCG alpha subunit.,NEUROENDOCRINE DIFFERENTIATION,LARGE CELL TYPE NEUROENDOCRINE TUMORS,RO-disease_has_finding
504170016,7/17/2014 12:15:50,,1325218829,7/17/2014 12:15:28,elite,0.6262,28503042,USA,NJ,Woodbridge,54.191.150.115,NEUROENDOCRINE DIFFERENTIATION causes LARGE CELL TYPE NEUROENDOCRINE TUMORS,298,203,,327,240,causes,0.356034497458156,901838-FS1-4,KTA7 was considered to be derived from large cell undifferentiated carcinoma with neuroendocrine differentiation (large cell neuroendocrine tumor) and thus may fine use in studies on the pathobiology of LARGE CELL TYPE NEUROENDOCRINE TUMORS since it expresses at the same time marker substances of NEUROENDOCRINE DIFFERENTIATION and the hCG alpha subunit.,NEUROENDOCRINE DIFFERENTIATION,LARGE CELL TYPE NEUROENDOCRINE TUMORS,RO-disease_has_finding
504170016,7/17/2014 12:30:56,,1325230660,7/17/2014 12:30:28,prodege,0.6827,7664351,USA,NY,Cicero,74.111.0.21,no_relation,298,203,,327,240,causes,0.356034497458156,901838-FS1-4,KTA7 was considered to be derived from large cell undifferentiated carcinoma with neuroendocrine differentiation (large cell neuroendocrine tumor) and thus may fine use in studies on the pathobiology of LARGE CELL TYPE NEUROENDOCRINE TUMORS since it expresses at the same time marker substances of NEUROENDOCRINE DIFFERENTIATION and the hCG alpha subunit.,NEUROENDOCRINE DIFFERENTIATION,LARGE CELL TYPE NEUROENDOCRINE TUMORS,RO-disease_has_finding
504170017,7/17/2014 10:27:44,,1325135965,7/17/2014 10:27:23,instagc,0.9583,24252915,GBR,B7,Bristol,77.98.139.82,no_relation,84,13,,90,23,causes,0.819288030372914,903897-FS1-4,Treatment of CANDIDEMIA is more complicated because of the changing epidemiology of CANDIDA and introduction of newer antifungal agents.,CANDIDA,CANDIDEMIA,RO-has_causative_agent
504170017,7/17/2014 11:26:58,,1325181780,7/17/2014 11:26:17,fusioncash,0.5583,7012325,USA,CT,Stamford,24.185.182.15,CANDIDA causes CANDIDEMIA,84,13,,90,23,causes,0.819288030372914,903897-FS1-4,Treatment of CANDIDEMIA is more complicated because of the changing epidemiology of CANDIDA and introduction of newer antifungal agents.,CANDIDA,CANDIDEMIA,RO-has_causative_agent
504170017,7/17/2014 11:52:14,,1325201646,7/17/2014 11:51:58,gifthulk,0.8375,21916793,GBR,"","",87.115.178.12,CANDIDA causes CANDIDEMIA,84,13,,90,23,causes,0.819288030372914,903897-FS1-4,Treatment of CANDIDEMIA is more complicated because of the changing epidemiology of CANDIDA and introduction of newer antifungal agents.,CANDIDA,CANDIDEMIA,RO-has_causative_agent
504170017,7/17/2014 11:54:32,,1325203231,7/17/2014 11:54:01,instagc,0.6653,13763729,USA,"","",75.182.89.225,no_relation,84,13,,90,23,causes,0.819288030372914,903897-FS1-4,Treatment of CANDIDEMIA is more complicated because of the changing epidemiology of CANDIDA and introduction of newer antifungal agents.,CANDIDA,CANDIDEMIA,RO-has_causative_agent
504170017,7/17/2014 11:57:27,,1325205052,7/17/2014 11:56:54,tremorgames,0.7111,24449707,CAN,QC,Laval,96.21.249.72,no_relation,84,13,,90,23,causes,0.819288030372914,903897-FS1-4,Treatment of CANDIDEMIA is more complicated because of the changing epidemiology of CANDIDA and introduction of newer antifungal agents.,CANDIDA,CANDIDEMIA,RO-has_causative_agent
504170017,7/17/2014 12:54:50,,1325250496,7/17/2014 12:54:38,clixsense,0.7,16827630,GBR,A7,Birmingham,86.146.169.103,CANDIDEMIA causes CANDIDA,84,13,,90,23,causes,0.819288030372914,903897-FS1-4,Treatment of CANDIDEMIA is more complicated because of the changing epidemiology of CANDIDA and introduction of newer antifungal agents.,CANDIDA,CANDIDEMIA,RO-has_causative_agent
504170017,7/17/2014 14:10:45,,1325320392,7/17/2014 14:10:09,clixsense,0.7183,27871219,NLD,07,Amsterdam,87.210.207.223,CANDIDA causes CANDIDEMIA,84,13,,90,23,causes,0.819288030372914,903897-FS1-4,Treatment of CANDIDEMIA is more complicated because of the changing epidemiology of CANDIDA and introduction of newer antifungal agents.,CANDIDA,CANDIDEMIA,RO-has_causative_agent
504170018,7/17/2014 11:19:39,,1325176607,7/17/2014 11:19:08,prodege,0.6597,27934334,GBR,"","",86.130.153.15,no_relation,98,131,,112,155,treats,0.439057039958762,902861-FS1-2,This case report draws the attention to the possibility of a conservative surgical treatment of a SPLENIC RUPTURE in the course of INFECTIOUS MONONUCLEOSIS,SPLENIC RUPTURE,INFECTIOUS MONONUCLEOSIS,RO-disease_may_have_finding
504170018,7/17/2014 11:23:15,,1325179292,7/17/2014 11:22:31,prodege,0.6181,15439740,AUS,02,Jannali,27.96.208.89,no_relation,98,131,,112,155,treats,0.439057039958762,902861-FS1-2,This case report draws the attention to the possibility of a conservative surgical treatment of a SPLENIC RUPTURE in the course of INFECTIOUS MONONUCLEOSIS,SPLENIC RUPTURE,INFECTIOUS MONONUCLEOSIS,RO-disease_may_have_finding
504170018,7/17/2014 11:52:14,,1325201655,7/17/2014 11:51:58,gifthulk,0.8375,21916793,GBR,"","",87.115.178.12,no_relation,98,131,,112,155,treats,0.439057039958762,902861-FS1-2,This case report draws the attention to the possibility of a conservative surgical treatment of a SPLENIC RUPTURE in the course of INFECTIOUS MONONUCLEOSIS,SPLENIC RUPTURE,INFECTIOUS MONONUCLEOSIS,RO-disease_may_have_finding
504170018,7/17/2014 12:55:30,,1325251027,7/17/2014 12:55:05,clixsense,0.7,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,98,131,,112,155,treats,0.439057039958762,902861-FS1-2,This case report draws the attention to the possibility of a conservative surgical treatment of a SPLENIC RUPTURE in the course of INFECTIOUS MONONUCLEOSIS,SPLENIC RUPTURE,INFECTIOUS MONONUCLEOSIS,RO-disease_may_have_finding
504170018,7/17/2014 13:39:06,,1325291273,7/17/2014 13:38:40,prodege,0.5202,28039757,GBR,L8,Southport,109.155.158.54,SPLENIC RUPTURE treats INFECTIOUS MONONUCLEOSIS,98,131,,112,155,treats,0.439057039958762,902861-FS1-2,This case report draws the attention to the possibility of a conservative surgical treatment of a SPLENIC RUPTURE in the course of INFECTIOUS MONONUCLEOSIS,SPLENIC RUPTURE,INFECTIOUS MONONUCLEOSIS,RO-disease_may_have_finding
504170018,7/17/2014 13:40:04,,1325292187,7/17/2014 13:39:26,clixsense,0.6825,6574199,USA,TX,San Antonio,207.230.144.242,no_relation,98,131,,112,155,treats,0.439057039958762,902861-FS1-2,This case report draws the attention to the possibility of a conservative surgical treatment of a SPLENIC RUPTURE in the course of INFECTIOUS MONONUCLEOSIS,SPLENIC RUPTURE,INFECTIOUS MONONUCLEOSIS,RO-disease_may_have_finding
504170018,7/17/2014 14:05:23,,1325315835,7/17/2014 14:04:51,clixsense,0.5901,15189335,GBR,T5,Aberdeen,90.218.222.164,no_relation,98,131,,112,155,treats,0.439057039958762,902861-FS1-2,This case report draws the attention to the possibility of a conservative surgical treatment of a SPLENIC RUPTURE in the course of INFECTIOUS MONONUCLEOSIS,SPLENIC RUPTURE,INFECTIOUS MONONUCLEOSIS,RO-disease_may_have_finding
504170019,7/17/2014 10:45:38,,1325150447,7/17/2014 10:45:25,prodege,0.8333,9525153,CAN,ON,Toronto,65.95.92.180,WOLFRAM SYNDROME causes DIABETES MELLITUS,46,0,,62,16,causes,0.997785157856609,906470-FS1-4,"WOLFRAM SYNDROME (WS), an infrequent cause of DIABETES MELLITUS derives its name from the physician who first reported the combination of juvenile onset diabetes mellitus and optic atrophy.",DIABETES MELLITUS,WOLFRAM SYNDROME,RO-has_manifestation
504170019,7/17/2014 11:22:15,,1325178649,7/17/2014 11:21:59,prodege,0.6181,15439740,AUS,02,Jannali,27.96.208.89,WOLFRAM SYNDROME causes DIABETES MELLITUS,46,0,,62,16,causes,0.997785157856609,906470-FS1-4,"WOLFRAM SYNDROME (WS), an infrequent cause of DIABETES MELLITUS derives its name from the physician who first reported the combination of juvenile onset diabetes mellitus and optic atrophy.",DIABETES MELLITUS,WOLFRAM SYNDROME,RO-has_manifestation
504170019,7/17/2014 11:27:44,,1325182358,7/17/2014 11:27:17,fusioncash,0.5583,7012325,USA,CT,Stamford,24.185.182.15,WOLFRAM SYNDROME causes DIABETES MELLITUS,46,0,,62,16,causes,0.997785157856609,906470-FS1-4,"WOLFRAM SYNDROME (WS), an infrequent cause of DIABETES MELLITUS derives its name from the physician who first reported the combination of juvenile onset diabetes mellitus and optic atrophy.",DIABETES MELLITUS,WOLFRAM SYNDROME,RO-has_manifestation
504170019,7/17/2014 13:39:45,,1325291888,7/17/2014 13:39:28,prodege,0.5202,28039757,GBR,L8,Southport,109.155.158.54,WOLFRAM SYNDROME causes DIABETES MELLITUS,46,0,,62,16,causes,0.997785157856609,906470-FS1-4,"WOLFRAM SYNDROME (WS), an infrequent cause of DIABETES MELLITUS derives its name from the physician who first reported the combination of juvenile onset diabetes mellitus and optic atrophy.",DIABETES MELLITUS,WOLFRAM SYNDROME,RO-has_manifestation
504170019,7/17/2014 14:04:49,,1325315354,7/17/2014 14:04:29,clixsense,0.5901,15189335,GBR,T5,Aberdeen,90.218.222.164,DIABETES MELLITUS causes WOLFRAM SYNDROME,46,0,,62,16,causes,0.997785157856609,906470-FS1-4,"WOLFRAM SYNDROME (WS), an infrequent cause of DIABETES MELLITUS derives its name from the physician who first reported the combination of juvenile onset diabetes mellitus and optic atrophy.",DIABETES MELLITUS,WOLFRAM SYNDROME,RO-has_manifestation
504170019,7/17/2014 14:05:36,,1325316034,7/17/2014 14:05:14,neodev,0.5669,18339121,USA,SC,Sumter,173.93.188.194,WOLFRAM SYNDROME causes DIABETES MELLITUS,46,0,,62,16,causes,0.997785157856609,906470-FS1-4,"WOLFRAM SYNDROME (WS), an infrequent cause of DIABETES MELLITUS derives its name from the physician who first reported the combination of juvenile onset diabetes mellitus and optic atrophy.",DIABETES MELLITUS,WOLFRAM SYNDROME,RO-has_manifestation
504170019,7/17/2014 14:30:17,,1325338487,7/17/2014 14:29:25,clixsense,0.4167,21830510,USA,NC,Greensboro,75.177.52.45,WOLFRAM SYNDROME causes DIABETES MELLITUS,46,0,,62,16,causes,0.997785157856609,906470-FS1-4,"WOLFRAM SYNDROME (WS), an infrequent cause of DIABETES MELLITUS derives its name from the physician who first reported the combination of juvenile onset diabetes mellitus and optic atrophy.",DIABETES MELLITUS,WOLFRAM SYNDROME,RO-has_manifestation
504170020,7/17/2014 10:34:50,,1325142030,7/17/2014 10:34:31,clixsense,0.8472,19162475,GBR,M3,Frome,82.33.126.30,VIREMIA causes VIRUS EXPOSURE,99,45,,112,52,causes,0.966736489045664,903998-FS1-4,Efficacious FeLV vaccines prevent persistent VIREMIA and development of FeLV related disease after VIRUS EXPOSURE but not minimal viral replication and a provirus positive state as recently demonstrated using sensitive real time PCR assays.,VIRUS EXPOSURE,VIREMIA,RO-has_causative_agent
504170020,7/17/2014 11:13:33,,1325171959,7/17/2014 11:13:18,clixsense,0.8958,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,VIREMIA causes VIRUS EXPOSURE,99,45,,112,52,causes,0.966736489045664,903998-FS1-4,Efficacious FeLV vaccines prevent persistent VIREMIA and development of FeLV related disease after VIRUS EXPOSURE but not minimal viral replication and a provirus positive state as recently demonstrated using sensitive real time PCR assays.,VIRUS EXPOSURE,VIREMIA,RO-has_causative_agent
504170020,7/17/2014 12:15:07,,1325218272,7/17/2014 12:14:51,elite,0.6262,28503042,USA,NJ,Woodbridge,54.191.150.115,VIRUS EXPOSURE causes VIREMIA,99,45,,112,52,causes,0.966736489045664,903998-FS1-4,Efficacious FeLV vaccines prevent persistent VIREMIA and development of FeLV related disease after VIRUS EXPOSURE but not minimal viral replication and a provirus positive state as recently demonstrated using sensitive real time PCR assays.,VIRUS EXPOSURE,VIREMIA,RO-has_causative_agent
504170020,7/17/2014 12:31:12,,1325230952,7/17/2014 12:30:56,prodege,0.6827,7664351,USA,NY,Cicero,74.111.0.21,VIRUS EXPOSURE causes VIREMIA,99,45,,112,52,causes,0.966736489045664,903998-FS1-4,Efficacious FeLV vaccines prevent persistent VIREMIA and development of FeLV related disease after VIRUS EXPOSURE but not minimal viral replication and a provirus positive state as recently demonstrated using sensitive real time PCR assays.,VIRUS EXPOSURE,VIREMIA,RO-has_causative_agent
504170020,7/17/2014 14:06:03,,1325316434,7/17/2014 14:05:38,neodev,0.5669,18339121,USA,SC,Sumter,173.93.188.194,VIRUS EXPOSURE causes VIREMIA,99,45,,112,52,causes,0.966736489045664,903998-FS1-4,Efficacious FeLV vaccines prevent persistent VIREMIA and development of FeLV related disease after VIRUS EXPOSURE but not minimal viral replication and a provirus positive state as recently demonstrated using sensitive real time PCR assays.,VIRUS EXPOSURE,VIREMIA,RO-has_causative_agent
504170020,7/17/2014 14:09:18,,1325319274,7/17/2014 14:08:53,clixsense,0.7183,27871219,NLD,07,Amsterdam,87.210.207.223,VIRUS EXPOSURE causes VIREMIA,99,45,,112,52,causes,0.966736489045664,903998-FS1-4,Efficacious FeLV vaccines prevent persistent VIREMIA and development of FeLV related disease after VIRUS EXPOSURE but not minimal viral replication and a provirus positive state as recently demonstrated using sensitive real time PCR assays.,VIRUS EXPOSURE,VIREMIA,RO-has_causative_agent
504170020,7/17/2014 14:30:17,,1325338481,7/17/2014 14:29:25,clixsense,0.4167,21830510,USA,NC,Greensboro,75.177.52.45,no_relation,99,45,,112,52,causes,0.966736489045664,903998-FS1-4,Efficacious FeLV vaccines prevent persistent VIREMIA and development of FeLV related disease after VIRUS EXPOSURE but not minimal viral replication and a provirus positive state as recently demonstrated using sensitive real time PCR assays.,VIRUS EXPOSURE,VIREMIA,RO-has_causative_agent
504170021,7/17/2014 10:22:43,,1325132236,7/17/2014 10:22:32,clixsense,1.0,27793793,GBR,C5,Chester,151.230.27.155,no_relation,73,210,,106,251,causes,0.788263422531435,903835-FS1-4,An understanding of the biologic characteristics and cellular tropism of HUMAN IMMUNODEFICIENCY VIRUS (HIV) is critical to appreciate the diverse neurologic manifestations of HIV infection in patients with the ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS),HUMAN IMMUNODEFICIENCY VIRUS (HIV),ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS),RO-has_causative_agent
504170021,7/17/2014 10:47:13,,1325151611,7/17/2014 10:46:40,prodege,0.8333,9525153,CAN,ON,Toronto,65.95.92.180,HUMAN IMMUNODEFICIENCY VIRUS (HIV) causes ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS),73,210,,106,251,causes,0.788263422531435,903835-FS1-4,An understanding of the biologic characteristics and cellular tropism of HUMAN IMMUNODEFICIENCY VIRUS (HIV) is critical to appreciate the diverse neurologic manifestations of HIV infection in patients with the ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS),HUMAN IMMUNODEFICIENCY VIRUS (HIV),ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS),RO-has_causative_agent
504170021,7/17/2014 11:10:25,,1325169071,7/17/2014 11:10:16,instagc,0.6556,23149109,USA,NC,Durham,75.189.206.205,ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) causes HUMAN IMMUNODEFICIENCY VIRUS (HIV),73,210,,106,251,causes,0.788263422531435,903835-FS1-4,An understanding of the biologic characteristics and cellular tropism of HUMAN IMMUNODEFICIENCY VIRUS (HIV) is critical to appreciate the diverse neurologic manifestations of HIV infection in patients with the ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS),HUMAN IMMUNODEFICIENCY VIRUS (HIV),ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS),RO-has_causative_agent
504170021,7/17/2014 13:24:12,,1325275544,7/17/2014 13:23:51,prodege,0.6909,24945126,GBR,F6,Romford,82.12.220.44,HUMAN IMMUNODEFICIENCY VIRUS (HIV) causes ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS),73,210,,106,251,causes,0.788263422531435,903835-FS1-4,An understanding of the biologic characteristics and cellular tropism of HUMAN IMMUNODEFICIENCY VIRUS (HIV) is critical to appreciate the diverse neurologic manifestations of HIV infection in patients with the ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS),HUMAN IMMUNODEFICIENCY VIRUS (HIV),ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS),RO-has_causative_agent
504170021,7/17/2014 14:01:11,,1325311901,7/17/2014 14:00:35,clixsense,0.6744,6579377,CAN,BC,Richmond,174.6.142.227,HUMAN IMMUNODEFICIENCY VIRUS (HIV) causes ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS),73,210,,106,251,causes,0.788263422531435,903835-FS1-4,An understanding of the biologic characteristics and cellular tropism of HUMAN IMMUNODEFICIENCY VIRUS (HIV) is critical to appreciate the diverse neurologic manifestations of HIV infection in patients with the ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS),HUMAN IMMUNODEFICIENCY VIRUS (HIV),ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS),RO-has_causative_agent
504170021,7/17/2014 14:06:28,,1325316723,7/17/2014 14:06:04,neodev,0.5669,18339121,USA,SC,Sumter,173.93.188.194,HUMAN IMMUNODEFICIENCY VIRUS (HIV) causes ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS),73,210,,106,251,causes,0.788263422531435,903835-FS1-4,An understanding of the biologic characteristics and cellular tropism of HUMAN IMMUNODEFICIENCY VIRUS (HIV) is critical to appreciate the diverse neurologic manifestations of HIV infection in patients with the ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS),HUMAN IMMUNODEFICIENCY VIRUS (HIV),ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS),RO-has_causative_agent
504170021,7/17/2014 14:10:08,,1325319925,7/17/2014 14:09:40,clixsense,0.7183,27871219,NLD,07,Amsterdam,87.210.207.223,HUMAN IMMUNODEFICIENCY VIRUS (HIV) causes ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS),73,210,,106,251,causes,0.788263422531435,903835-FS1-4,An understanding of the biologic characteristics and cellular tropism of HUMAN IMMUNODEFICIENCY VIRUS (HIV) is critical to appreciate the diverse neurologic manifestations of HIV infection in patients with the ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS),HUMAN IMMUNODEFICIENCY VIRUS (HIV),ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS),RO-has_causative_agent
504170022,7/17/2014 10:27:44,,1325135971,7/17/2014 10:27:23,instagc,0.9583,24252915,GBR,B7,Bristol,77.98.139.82,ALLERGY causes HYPERSENSITIVITY REACTION,93,7,,117,14,causes,0.787561530648217,900292-FS1-4,SEE:   ALLERGY ;  anaphylaxis  ETIOLOGY: The condition is the result of a type I allergic or HYPERSENSITIVITY REACTION during which the allergen is absorbed into the blood directly or through the mucosa.,HYPERSENSITIVITY REACTION,ALLERGY,RO-cause_of
504170022,7/17/2014 10:38:54,,1325145117,7/17/2014 10:38:36,clixsense,0.8958,19803139,NLD,06,Veldhoven,212.61.84.196,ALLERGY causes HYPERSENSITIVITY REACTION,93,7,,117,14,causes,0.787561530648217,900292-FS1-4,SEE:   ALLERGY ;  anaphylaxis  ETIOLOGY: The condition is the result of a type I allergic or HYPERSENSITIVITY REACTION during which the allergen is absorbed into the blood directly or through the mucosa.,HYPERSENSITIVITY REACTION,ALLERGY,RO-cause_of
504170022,7/17/2014 11:12:58,,1325171434,7/17/2014 11:12:42,clixsense,0.8958,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,ALLERGY causes HYPERSENSITIVITY REACTION,93,7,,117,14,causes,0.787561530648217,900292-FS1-4,SEE:   ALLERGY ;  anaphylaxis  ETIOLOGY: The condition is the result of a type I allergic or HYPERSENSITIVITY REACTION during which the allergen is absorbed into the blood directly or through the mucosa.,HYPERSENSITIVITY REACTION,ALLERGY,RO-cause_of
504170022,7/17/2014 11:16:35,,1325174295,7/17/2014 11:16:00,prodege,0.6597,27934334,GBR,"","",86.130.153.15,no_relation,93,7,,117,14,causes,0.787561530648217,900292-FS1-4,SEE:   ALLERGY ;  anaphylaxis  ETIOLOGY: The condition is the result of a type I allergic or HYPERSENSITIVITY REACTION during which the allergen is absorbed into the blood directly or through the mucosa.,HYPERSENSITIVITY REACTION,ALLERGY,RO-cause_of
504170022,7/17/2014 11:25:40,,1325180930,7/17/2014 11:25:01,fusioncash,0.5583,7012325,USA,CT,Stamford,24.185.182.15,HYPERSENSITIVITY REACTION causes ALLERGY,93,7,,117,14,causes,0.787561530648217,900292-FS1-4,SEE:   ALLERGY ;  anaphylaxis  ETIOLOGY: The condition is the result of a type I allergic or HYPERSENSITIVITY REACTION during which the allergen is absorbed into the blood directly or through the mucosa.,HYPERSENSITIVITY REACTION,ALLERGY,RO-cause_of
504170022,7/17/2014 11:51:28,,1325201134,7/17/2014 11:51:18,gifthulk,0.8375,21916793,GBR,"","",87.115.178.12,ALLERGY causes HYPERSENSITIVITY REACTION,93,7,,117,14,causes,0.787561530648217,900292-FS1-4,SEE:   ALLERGY ;  anaphylaxis  ETIOLOGY: The condition is the result of a type I allergic or HYPERSENSITIVITY REACTION during which the allergen is absorbed into the blood directly or through the mucosa.,HYPERSENSITIVITY REACTION,ALLERGY,RO-cause_of
504170022,7/17/2014 12:14:49,,1325218046,7/17/2014 12:14:14,elite,0.6262,28503042,USA,NJ,Woodbridge,54.191.150.115,ALLERGY causes HYPERSENSITIVITY REACTION,93,7,,117,14,causes,0.787561530648217,900292-FS1-4,SEE:   ALLERGY ;  anaphylaxis  ETIOLOGY: The condition is the result of a type I allergic or HYPERSENSITIVITY REACTION during which the allergen is absorbed into the blood directly or through the mucosa.,HYPERSENSITIVITY REACTION,ALLERGY,RO-cause_of
504170023,7/17/2014 10:26:44,,1325135259,7/17/2014 10:26:20,instagc,0.9583,24252915,GBR,B7,Bristol,77.98.139.82,no_relation,170,96,,193,112,causes,0.714285714285714,903698-FS1-4,"Recent studies indicate, however, that the prevalence and, to a lesser extent, the intensity of DENTAL FLUOROSIS have increased in schoolchildren in both fluoridated and FLUORIDE DEFICIENT AREAS.",FLUORIDE DEFICIENT AREAS,DENTAL FLUOROSIS,RO-has_causative_agent
504170023,7/17/2014 11:51:57,,1325201408,7/17/2014 11:51:40,gifthulk,0.8375,21916793,GBR,"","",87.115.178.12,FLUORIDE DEFICIENT AREAS causes DENTAL FLUOROSIS,170,96,,193,112,causes,0.714285714285714,903698-FS1-4,"Recent studies indicate, however, that the prevalence and, to a lesser extent, the intensity of DENTAL FLUOROSIS have increased in schoolchildren in both fluoridated and FLUORIDE DEFICIENT AREAS.",FLUORIDE DEFICIENT AREAS,DENTAL FLUOROSIS,RO-has_causative_agent
504170023,7/17/2014 11:53:34,,1325202665,7/17/2014 11:53:20,instagc,0.6653,13763729,USA,"","",75.182.89.225,FLUORIDE DEFICIENT AREAS causes DENTAL FLUOROSIS,170,96,,193,112,causes,0.714285714285714,903698-FS1-4,"Recent studies indicate, however, that the prevalence and, to a lesser extent, the intensity of DENTAL FLUOROSIS have increased in schoolchildren in both fluoridated and FLUORIDE DEFICIENT AREAS.",FLUORIDE DEFICIENT AREAS,DENTAL FLUOROSIS,RO-has_causative_agent
504170023,7/17/2014 13:40:21,,1325292488,7/17/2014 13:39:46,prodege,0.5202,28039757,GBR,L8,Southport,109.155.158.54,no_relation,170,96,,193,112,causes,0.714285714285714,903698-FS1-4,"Recent studies indicate, however, that the prevalence and, to a lesser extent, the intensity of DENTAL FLUOROSIS have increased in schoolchildren in both fluoridated and FLUORIDE DEFICIENT AREAS.",FLUORIDE DEFICIENT AREAS,DENTAL FLUOROSIS,RO-has_causative_agent
504170023,7/17/2014 14:32:09,,1325340092,7/17/2014 14:32:00,clixsense,0.4918,20614047,USA,MO,Maryville,174.32.162.147,FLUORIDE DEFICIENT AREAS causes DENTAL FLUOROSIS,170,96,,193,112,causes,0.714285714285714,903698-FS1-4,"Recent studies indicate, however, that the prevalence and, to a lesser extent, the intensity of DENTAL FLUOROSIS have increased in schoolchildren in both fluoridated and FLUORIDE DEFICIENT AREAS.",FLUORIDE DEFICIENT AREAS,DENTAL FLUOROSIS,RO-has_causative_agent
504170023,7/17/2014 15:04:38,,1325369304,7/17/2014 15:04:11,elite,0.534,28276268,USA,MI,Taylor,67.149.247.166,DENTAL FLUOROSIS causes FLUORIDE DEFICIENT AREAS,170,96,,193,112,causes,0.714285714285714,903698-FS1-4,"Recent studies indicate, however, that the prevalence and, to a lesser extent, the intensity of DENTAL FLUOROSIS have increased in schoolchildren in both fluoridated and FLUORIDE DEFICIENT AREAS.",FLUORIDE DEFICIENT AREAS,DENTAL FLUOROSIS,RO-has_causative_agent
504170023,7/17/2014 15:43:04,,1325404074,7/17/2014 15:42:43,prodege,0.4155,24403612,CAN,ON,Ajax,99.242.234.239,no_relation,170,96,,193,112,causes,0.714285714285714,903698-FS1-4,"Recent studies indicate, however, that the prevalence and, to a lesser extent, the intensity of DENTAL FLUOROSIS have increased in schoolchildren in both fluoridated and FLUORIDE DEFICIENT AREAS.",FLUORIDE DEFICIENT AREAS,DENTAL FLUOROSIS,RO-has_causative_agent
504170024,7/17/2014 10:39:46,,1325145854,7/17/2014 10:39:25,clixsense,0.8958,19803139,NLD,06,Veldhoven,212.61.84.196,no_relation,0,0,,7,20,causes,0.643267520902677,903841-FS1-4,MECONIUM PERITONITIS occasionally occurs as a localized collection of MECONIUM contained in a cyst made of fibrous granulation tissue.,MECONIUM,MECONIUM PERITONITIS,RO-has_causative_agent
504170024,7/17/2014 13:40:21,,1325292447,7/17/2014 13:39:46,prodege,0.5202,28039757,GBR,L8,Southport,109.155.158.54,MECONIUM causes MECONIUM PERITONITIS,0,0,,7,20,causes,0.643267520902677,903841-FS1-4,MECONIUM PERITONITIS occasionally occurs as a localized collection of MECONIUM contained in a cyst made of fibrous granulation tissue.,MECONIUM,MECONIUM PERITONITIS,RO-has_causative_agent
504170024,7/17/2014 14:09:38,,1325319549,7/17/2014 14:09:18,clixsense,0.7183,27871219,NLD,07,Amsterdam,87.210.207.223,MECONIUM causes MECONIUM PERITONITIS,0,0,,7,20,causes,0.643267520902677,903841-FS1-4,MECONIUM PERITONITIS occasionally occurs as a localized collection of MECONIUM contained in a cyst made of fibrous granulation tissue.,MECONIUM,MECONIUM PERITONITIS,RO-has_causative_agent
504170024,7/17/2014 14:32:09,,1325340109,7/17/2014 14:32:00,clixsense,0.4918,20614047,USA,MO,Maryville,174.32.162.147,no_relation,0,0,,7,20,causes,0.643267520902677,903841-FS1-4,MECONIUM PERITONITIS occasionally occurs as a localized collection of MECONIUM contained in a cyst made of fibrous granulation tissue.,MECONIUM,MECONIUM PERITONITIS,RO-has_causative_agent
504170024,7/17/2014 15:05:04,,1325369674,7/17/2014 15:04:41,elite,0.534,28276268,USA,MI,Taylor,67.149.247.166,MECONIUM PERITONITIS causes MECONIUM,0,0,,7,20,causes,0.643267520902677,903841-FS1-4,MECONIUM PERITONITIS occasionally occurs as a localized collection of MECONIUM contained in a cyst made of fibrous granulation tissue.,MECONIUM,MECONIUM PERITONITIS,RO-has_causative_agent
504170024,7/17/2014 15:43:24,,1325404347,7/17/2014 15:43:06,prodege,0.4155,24403612,CAN,ON,Ajax,99.242.234.239,no_relation,0,0,,7,20,causes,0.643267520902677,903841-FS1-4,MECONIUM PERITONITIS occasionally occurs as a localized collection of MECONIUM contained in a cyst made of fibrous granulation tissue.,MECONIUM,MECONIUM PERITONITIS,RO-has_causative_agent
504170024,7/17/2014 15:48:35,,1325408603,7/17/2014 15:48:28,prodege,0.754,23541832,USA,AZ,Tempe,149.169.145.152,no_relation,0,0,,7,20,causes,0.643267520902677,903841-FS1-4,MECONIUM PERITONITIS occasionally occurs as a localized collection of MECONIUM contained in a cyst made of fibrous granulation tissue.,MECONIUM,MECONIUM PERITONITIS,RO-has_causative_agent
504170025,7/17/2014 10:35:05,,1325142283,7/17/2014 10:34:58,clixsense,0.8472,19162475,GBR,M3,Frome,82.33.126.30,SPLENIC RUPTURE causes INFECTIOUS MONONUCLEOSIS,98,131,,112,155,causes,0.878114079917523,902861-FS1-4,This case report draws the attention to the possibility of a conservative surgical treatment of a SPLENIC RUPTURE in the course of INFECTIOUS MONONUCLEOSIS,SPLENIC RUPTURE,INFECTIOUS MONONUCLEOSIS,RO-disease_may_have_finding
504170025,7/17/2014 10:39:24,,1325145541,7/17/2014 10:38:56,clixsense,0.8958,19803139,NLD,06,Veldhoven,212.61.84.196,no_relation,98,131,,112,155,causes,0.878114079917523,902861-FS1-4,This case report draws the attention to the possibility of a conservative surgical treatment of a SPLENIC RUPTURE in the course of INFECTIOUS MONONUCLEOSIS,SPLENIC RUPTURE,INFECTIOUS MONONUCLEOSIS,RO-disease_may_have_finding
504170025,7/17/2014 12:16:10,,1325219184,7/17/2014 12:15:52,elite,0.6262,28503042,USA,NJ,Woodbridge,54.191.150.115,INFECTIOUS MONONUCLEOSIS causes SPLENIC RUPTURE,98,131,,112,155,causes,0.878114079917523,902861-FS1-4,This case report draws the attention to the possibility of a conservative surgical treatment of a SPLENIC RUPTURE in the course of INFECTIOUS MONONUCLEOSIS,SPLENIC RUPTURE,INFECTIOUS MONONUCLEOSIS,RO-disease_may_have_finding
504170025,7/17/2014 12:31:33,,1325231279,7/17/2014 12:31:13,prodege,0.6827,7664351,USA,NY,Cicero,74.111.0.21,no_relation,98,131,,112,155,causes,0.878114079917523,902861-FS1-4,This case report draws the attention to the possibility of a conservative surgical treatment of a SPLENIC RUPTURE in the course of INFECTIOUS MONONUCLEOSIS,SPLENIC RUPTURE,INFECTIOUS MONONUCLEOSIS,RO-disease_may_have_finding
504170025,7/17/2014 13:37:34,,1325289823,7/17/2014 13:36:57,clixsense,0.6825,6574199,USA,TX,San Antonio,207.230.144.242,INFECTIOUS MONONUCLEOSIS causes SPLENIC RUPTURE,98,131,,112,155,causes,0.878114079917523,902861-FS1-4,This case report draws the attention to the possibility of a conservative surgical treatment of a SPLENIC RUPTURE in the course of INFECTIOUS MONONUCLEOSIS,SPLENIC RUPTURE,INFECTIOUS MONONUCLEOSIS,RO-disease_may_have_finding
504170025,7/17/2014 14:00:16,,1325310917,7/17/2014 13:59:57,clixsense,0.6744,6579377,CAN,BC,Richmond,174.6.142.227,INFECTIOUS MONONUCLEOSIS causes SPLENIC RUPTURE,98,131,,112,155,causes,0.878114079917523,902861-FS1-4,This case report draws the attention to the possibility of a conservative surgical treatment of a SPLENIC RUPTURE in the course of INFECTIOUS MONONUCLEOSIS,SPLENIC RUPTURE,INFECTIOUS MONONUCLEOSIS,RO-disease_may_have_finding
504170025,7/17/2014 14:06:28,,1325316710,7/17/2014 14:06:04,neodev,0.5669,18339121,USA,SC,Sumter,173.93.188.194,SPLENIC RUPTURE causes INFECTIOUS MONONUCLEOSIS,98,131,,112,155,causes,0.878114079917523,902861-FS1-4,This case report draws the attention to the possibility of a conservative surgical treatment of a SPLENIC RUPTURE in the course of INFECTIOUS MONONUCLEOSIS,SPLENIC RUPTURE,INFECTIOUS MONONUCLEOSIS,RO-disease_may_have_finding
504170026,7/17/2014 11:10:25,,1325169084,7/17/2014 11:10:16,instagc,0.6556,23149109,USA,NC,Durham,75.189.206.205,VARIOLA VIRUS causes SMALLPOX,77,104,,89,112,causes,0.983078304622849,903571-FS1-4,Each comparison gave the same conclusion: CMPV is the closest known virus to VARIOLA VIRUS the cause of SMALLPOX,VARIOLA VIRUS,SMALLPOX,RO-has_causative_agent
504170026,7/17/2014 11:27:16,,1325182006,7/17/2014 11:26:59,fusioncash,0.5583,7012325,USA,CT,Stamford,24.185.182.15,VARIOLA VIRUS causes SMALLPOX,77,104,,89,112,causes,0.983078304622849,903571-FS1-4,Each comparison gave the same conclusion: CMPV is the closest known virus to VARIOLA VIRUS the cause of SMALLPOX,VARIOLA VIRUS,SMALLPOX,RO-has_causative_agent
504170026,7/17/2014 14:11:22,,1325321052,7/17/2014 14:11:06,clixsense,0.7183,27871219,NLD,07,Amsterdam,87.210.207.223,VARIOLA VIRUS causes SMALLPOX,77,104,,89,112,causes,0.983078304622849,903571-FS1-4,Each comparison gave the same conclusion: CMPV is the closest known virus to VARIOLA VIRUS the cause of SMALLPOX,VARIOLA VIRUS,SMALLPOX,RO-has_causative_agent
504170026,7/17/2014 14:32:38,,1325340474,7/17/2014 14:32:27,clixsense,0.4918,20614047,USA,MO,Maryville,174.32.162.147,SMALLPOX causes VARIOLA VIRUS,77,104,,89,112,causes,0.983078304622849,903571-FS1-4,Each comparison gave the same conclusion: CMPV is the closest known virus to VARIOLA VIRUS the cause of SMALLPOX,VARIOLA VIRUS,SMALLPOX,RO-has_causative_agent
504170026,7/17/2014 15:05:34,,1325370256,7/17/2014 15:05:11,elite,0.534,28276268,USA,MI,Taylor,67.149.247.166,VARIOLA VIRUS causes SMALLPOX,77,104,,89,112,causes,0.983078304622849,903571-FS1-4,Each comparison gave the same conclusion: CMPV is the closest known virus to VARIOLA VIRUS the cause of SMALLPOX,VARIOLA VIRUS,SMALLPOX,RO-has_causative_agent
504170026,7/17/2014 15:43:04,,1325404071,7/17/2014 15:42:43,prodege,0.4155,24403612,CAN,ON,Ajax,99.242.234.239,VARIOLA VIRUS causes SMALLPOX,77,104,,89,112,causes,0.983078304622849,903571-FS1-4,Each comparison gave the same conclusion: CMPV is the closest known virus to VARIOLA VIRUS the cause of SMALLPOX,VARIOLA VIRUS,SMALLPOX,RO-has_causative_agent
504170026,7/17/2014 15:48:27,,1325408511,7/17/2014 15:48:08,prodege,0.754,23541832,USA,AZ,Tempe,149.169.145.152,VARIOLA VIRUS causes SMALLPOX,77,104,,89,112,causes,0.983078304622849,903571-FS1-4,Each comparison gave the same conclusion: CMPV is the closest known virus to VARIOLA VIRUS the cause of SMALLPOX,VARIOLA VIRUS,SMALLPOX,RO-has_causative_agent
504170027,7/17/2014 10:22:31,,1325132085,7/17/2014 10:22:22,clixsense,1.0,27793793,GBR,C5,Chester,151.230.27.155,PARTIAL EPILEPSY causes SEIZURES,89,52,,96,68,causes,0.985329278164293,904841-FS1-4,During therapy of 40 patients (8 57 year olds) with PARTIAL EPILEPSY the severity of the SEIZURES as well as emotional and cognitive functions of the patients were evaluated.,SEIZURES,PARTIAL EPILEPSY,RO-has_definitional_manifestation
504170027,7/17/2014 11:13:33,,1325171958,7/17/2014 11:13:18,clixsense,0.8958,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,PARTIAL EPILEPSY causes SEIZURES,89,52,,96,68,causes,0.985329278164293,904841-FS1-4,During therapy of 40 patients (8 57 year olds) with PARTIAL EPILEPSY the severity of the SEIZURES as well as emotional and cognitive functions of the patients were evaluated.,SEIZURES,PARTIAL EPILEPSY,RO-has_definitional_manifestation
504170027,7/17/2014 11:21:57,,1325178420,7/17/2014 11:21:25,prodege,0.6181,15439740,AUS,02,Jannali,27.96.208.89,SEIZURES causes PARTIAL EPILEPSY,89,52,,96,68,causes,0.985329278164293,904841-FS1-4,During therapy of 40 patients (8 57 year olds) with PARTIAL EPILEPSY the severity of the SEIZURES as well as emotional and cognitive functions of the patients were evaluated.,SEIZURES,PARTIAL EPILEPSY,RO-has_definitional_manifestation
504170027,7/17/2014 11:56:27,,1325204459,7/17/2014 11:56:08,tremorgames,0.7111,24449707,CAN,QC,Laval,96.21.249.72,PARTIAL EPILEPSY causes SEIZURES,89,52,,96,68,causes,0.985329278164293,904841-FS1-4,During therapy of 40 patients (8 57 year olds) with PARTIAL EPILEPSY the severity of the SEIZURES as well as emotional and cognitive functions of the patients were evaluated.,SEIZURES,PARTIAL EPILEPSY,RO-has_definitional_manifestation
504170027,7/17/2014 12:55:04,,1325250655,7/17/2014 12:54:52,clixsense,0.7,16827630,GBR,A7,Birmingham,86.146.169.103,PARTIAL EPILEPSY causes SEIZURES,89,52,,96,68,causes,0.985329278164293,904841-FS1-4,During therapy of 40 patients (8 57 year olds) with PARTIAL EPILEPSY the severity of the SEIZURES as well as emotional and cognitive functions of the patients were evaluated.,SEIZURES,PARTIAL EPILEPSY,RO-has_definitional_manifestation
504170027,7/17/2014 13:38:57,,1325291109,7/17/2014 13:38:39,clixsense,0.6825,6574199,USA,TX,San Antonio,207.230.144.242,PARTIAL EPILEPSY causes SEIZURES,89,52,,96,68,causes,0.985329278164293,904841-FS1-4,During therapy of 40 patients (8 57 year olds) with PARTIAL EPILEPSY the severity of the SEIZURES as well as emotional and cognitive functions of the patients were evaluated.,SEIZURES,PARTIAL EPILEPSY,RO-has_definitional_manifestation
504170027,7/17/2014 13:39:06,,1325291277,7/17/2014 13:38:40,prodege,0.5202,28039757,GBR,L8,Southport,109.155.158.54,no_relation,89,52,,96,68,causes,0.985329278164293,904841-FS1-4,During therapy of 40 patients (8 57 year olds) with PARTIAL EPILEPSY the severity of the SEIZURES as well as emotional and cognitive functions of the patients were evaluated.,SEIZURES,PARTIAL EPILEPSY,RO-has_definitional_manifestation
504170028,7/17/2014 10:34:22,,1325141667,7/17/2014 10:33:52,clixsense,0.8472,19162475,GBR,M3,Frome,82.33.126.30,TOPICAL MINOXIDIL treats MALE PATTERN BALDNESS,64,99,,84,116,treats,0.99654575824488,907885-FS1-2,"Olsen EA, DeLong ER, Weiner MS. Long term follow up of men with MALE PATTERN BALDNESS treated with TOPICAL MINOXIDIL",MALE PATTERN BALDNESS,TOPICAL MINOXIDIL,RO-may_treat
504170028,7/17/2014 11:13:17,,1325171680,7/17/2014 11:12:59,clixsense,0.8958,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,TOPICAL MINOXIDIL treats MALE PATTERN BALDNESS,64,99,,84,116,treats,0.99654575824488,907885-FS1-2,"Olsen EA, DeLong ER, Weiner MS. Long term follow up of men with MALE PATTERN BALDNESS treated with TOPICAL MINOXIDIL",MALE PATTERN BALDNESS,TOPICAL MINOXIDIL,RO-may_treat
504170028,7/17/2014 11:16:35,,1325174296,7/17/2014 11:16:00,prodege,0.6597,27934334,GBR,"","",86.130.153.15,TOPICAL MINOXIDIL treats MALE PATTERN BALDNESS,64,99,,84,116,treats,0.99654575824488,907885-FS1-2,"Olsen EA, DeLong ER, Weiner MS. Long term follow up of men with MALE PATTERN BALDNESS treated with TOPICAL MINOXIDIL",MALE PATTERN BALDNESS,TOPICAL MINOXIDIL,RO-may_treat
504170028,7/17/2014 12:31:12,,1325230955,7/17/2014 12:30:56,prodege,0.6827,7664351,USA,NY,Cicero,74.111.0.21,TOPICAL MINOXIDIL treats MALE PATTERN BALDNESS,64,99,,84,116,treats,0.99654575824488,907885-FS1-2,"Olsen EA, DeLong ER, Weiner MS. Long term follow up of men with MALE PATTERN BALDNESS treated with TOPICAL MINOXIDIL",MALE PATTERN BALDNESS,TOPICAL MINOXIDIL,RO-may_treat
504170028,7/17/2014 13:10:24,,1325263583,7/17/2014 13:09:44,neodev,0.7137,21515166,NLD,11,Nootdorp,83.86.58.179,TOPICAL MINOXIDIL treats MALE PATTERN BALDNESS,64,99,,84,116,treats,0.99654575824488,907885-FS1-2,"Olsen EA, DeLong ER, Weiner MS. Long term follow up of men with MALE PATTERN BALDNESS treated with TOPICAL MINOXIDIL",MALE PATTERN BALDNESS,TOPICAL MINOXIDIL,RO-may_treat
504170028,7/17/2014 13:39:24,,1325291543,7/17/2014 13:38:58,clixsense,0.6825,6574199,USA,TX,San Antonio,207.230.144.242,TOPICAL MINOXIDIL treats MALE PATTERN BALDNESS,64,99,,84,116,treats,0.99654575824488,907885-FS1-2,"Olsen EA, DeLong ER, Weiner MS. Long term follow up of men with MALE PATTERN BALDNESS treated with TOPICAL MINOXIDIL",MALE PATTERN BALDNESS,TOPICAL MINOXIDIL,RO-may_treat
504170028,7/17/2014 13:39:26,,1325291607,7/17/2014 13:39:06,prodege,0.5202,28039757,GBR,L8,Southport,109.155.158.54,TOPICAL MINOXIDIL treats MALE PATTERN BALDNESS,64,99,,84,116,treats,0.99654575824488,907885-FS1-2,"Olsen EA, DeLong ER, Weiner MS. Long term follow up of men with MALE PATTERN BALDNESS treated with TOPICAL MINOXIDIL",MALE PATTERN BALDNESS,TOPICAL MINOXIDIL,RO-may_treat
504170029,7/17/2014 10:47:29,,1325151863,7/17/2014 10:47:15,prodege,0.8333,9525153,CAN,ON,Toronto,65.95.92.180,PATELLO FEMORAL JOINT treats ARTHROSIS OF THE KNEE,44,109,,64,130,treats,0.337526370277807,902308-FS1-2,The progressive radiological changes in the PATELLO FEMORAL JOINT after upper tibial osteotomy performed for ARTHROSIS OF THE KNEE were studied more than 10 years after the surgical procedure.,PATELLO FEMORAL JOINT,ARTHROSIS OF THE KNEE,RO-disease_has_primary_anatomic_site
504170029,7/17/2014 11:51:39,,1325201238,7/17/2014 11:51:29,gifthulk,0.8375,21916793,GBR,"","",87.115.178.12,no_relation,44,109,,64,130,treats,0.337526370277807,902308-FS1-2,The progressive radiological changes in the PATELLO FEMORAL JOINT after upper tibial osteotomy performed for ARTHROSIS OF THE KNEE were studied more than 10 years after the surgical procedure.,PATELLO FEMORAL JOINT,ARTHROSIS OF THE KNEE,RO-disease_has_primary_anatomic_site
504170029,7/17/2014 13:11:17,,1325264372,7/17/2014 13:10:50,neodev,0.7137,21515166,NLD,11,Nootdorp,83.86.58.179,PATELLO FEMORAL JOINT treats ARTHROSIS OF THE KNEE,44,109,,64,130,treats,0.337526370277807,902308-FS1-2,The progressive radiological changes in the PATELLO FEMORAL JOINT after upper tibial osteotomy performed for ARTHROSIS OF THE KNEE were studied more than 10 years after the surgical procedure.,PATELLO FEMORAL JOINT,ARTHROSIS OF THE KNEE,RO-disease_has_primary_anatomic_site
504170029,7/17/2014 13:25:14,,1325276593,7/17/2014 13:24:35,prodege,0.6909,24945126,GBR,F6,Romford,82.12.220.44,no_relation,44,109,,64,130,treats,0.337526370277807,902308-FS1-2,The progressive radiological changes in the PATELLO FEMORAL JOINT after upper tibial osteotomy performed for ARTHROSIS OF THE KNEE were studied more than 10 years after the surgical procedure.,PATELLO FEMORAL JOINT,ARTHROSIS OF THE KNEE,RO-disease_has_primary_anatomic_site
504170029,7/17/2014 13:38:39,,1325290763,7/17/2014 13:38:04,prodege,0.5202,28039757,GBR,L8,Southport,109.155.158.54,no_relation,44,109,,64,130,treats,0.337526370277807,902308-FS1-2,The progressive radiological changes in the PATELLO FEMORAL JOINT after upper tibial osteotomy performed for ARTHROSIS OF THE KNEE were studied more than 10 years after the surgical procedure.,PATELLO FEMORAL JOINT,ARTHROSIS OF THE KNEE,RO-disease_has_primary_anatomic_site
504170029,7/17/2014 14:05:23,,1325315873,7/17/2014 14:04:51,clixsense,0.5901,15189335,GBR,T5,Aberdeen,90.218.222.164,no_relation,44,109,,64,130,treats,0.337526370277807,902308-FS1-2,The progressive radiological changes in the PATELLO FEMORAL JOINT after upper tibial osteotomy performed for ARTHROSIS OF THE KNEE were studied more than 10 years after the surgical procedure.,PATELLO FEMORAL JOINT,ARTHROSIS OF THE KNEE,RO-disease_has_primary_anatomic_site
504170029,7/17/2014 14:10:08,,1325319927,7/17/2014 14:09:40,clixsense,0.7183,27871219,NLD,07,Amsterdam,87.210.207.223,no_relation,44,109,,64,130,treats,0.337526370277807,902308-FS1-2,The progressive radiological changes in the PATELLO FEMORAL JOINT after upper tibial osteotomy performed for ARTHROSIS OF THE KNEE were studied more than 10 years after the surgical procedure.,PATELLO FEMORAL JOINT,ARTHROSIS OF THE KNEE,RO-disease_has_primary_anatomic_site
504170030,7/17/2014 10:35:13,,1325142467,7/17/2014 10:35:07,clixsense,0.8472,19162475,GBR,M3,Frome,82.33.126.30,DRUG INDUCED DERMATITIS causes SKIN LESIONS,129,39,,140,62,causes,0.596284793999944,902348-FS1-4,Skin biopsies from eight patients with DRUG INDUCED DERMATITIS have been compared with skin biopsies from 16 patients developing SKIN LESIONS (acute graft versus host reaction and/or drug induced reaction) after bone marrow transplantation.,SKIN LESIONS,DRUG INDUCED DERMATITIS,RO-disease_has_primary_anatomic_site
504170030,7/17/2014 10:46:39,,1325151219,7/17/2014 10:46:14,prodege,0.8333,9525153,CAN,ON,Toronto,65.95.92.180,DRUG INDUCED DERMATITIS causes SKIN LESIONS,129,39,,140,62,causes,0.596284793999944,902348-FS1-4,Skin biopsies from eight patients with DRUG INDUCED DERMATITIS have been compared with skin biopsies from 16 patients developing SKIN LESIONS (acute graft versus host reaction and/or drug induced reaction) after bone marrow transplantation.,SKIN LESIONS,DRUG INDUCED DERMATITIS,RO-disease_has_primary_anatomic_site
504170030,7/17/2014 11:19:07,,1325176288,7/17/2014 11:18:36,prodege,0.6597,27934334,GBR,"","",86.130.153.15,no_relation,129,39,,140,62,causes,0.596284793999944,902348-FS1-4,Skin biopsies from eight patients with DRUG INDUCED DERMATITIS have been compared with skin biopsies from 16 patients developing SKIN LESIONS (acute graft versus host reaction and/or drug induced reaction) after bone marrow transplantation.,SKIN LESIONS,DRUG INDUCED DERMATITIS,RO-disease_has_primary_anatomic_site
504170030,7/17/2014 11:56:06,,1325204327,7/17/2014 11:55:38,tremorgames,0.7111,24449707,CAN,QC,Laval,96.21.249.72,DRUG INDUCED DERMATITIS causes SKIN LESIONS,129,39,,140,62,causes,0.596284793999944,902348-FS1-4,Skin biopsies from eight patients with DRUG INDUCED DERMATITIS have been compared with skin biopsies from 16 patients developing SKIN LESIONS (acute graft versus host reaction and/or drug induced reaction) after bone marrow transplantation.,SKIN LESIONS,DRUG INDUCED DERMATITIS,RO-disease_has_primary_anatomic_site
504170030,7/17/2014 12:32:40,,1325232082,7/17/2014 12:32:10,prodege,0.6827,7664351,USA,NY,Cicero,74.111.0.21,no_relation,129,39,,140,62,causes,0.596284793999944,902348-FS1-4,Skin biopsies from eight patients with DRUG INDUCED DERMATITIS have been compared with skin biopsies from 16 patients developing SKIN LESIONS (acute graft versus host reaction and/or drug induced reaction) after bone marrow transplantation.,SKIN LESIONS,DRUG INDUCED DERMATITIS,RO-disease_has_primary_anatomic_site
504170030,7/17/2014 12:54:37,,1325250313,7/17/2014 12:54:25,clixsense,0.7,16827630,GBR,A7,Birmingham,86.146.169.103,DRUG INDUCED DERMATITIS causes SKIN LESIONS,129,39,,140,62,causes,0.596284793999944,902348-FS1-4,Skin biopsies from eight patients with DRUG INDUCED DERMATITIS have been compared with skin biopsies from 16 patients developing SKIN LESIONS (acute graft versus host reaction and/or drug induced reaction) after bone marrow transplantation.,SKIN LESIONS,DRUG INDUCED DERMATITIS,RO-disease_has_primary_anatomic_site
504170030,7/17/2014 14:05:36,,1325316062,7/17/2014 14:05:14,neodev,0.5669,18339121,USA,SC,Sumter,173.93.188.194,DRUG INDUCED DERMATITIS causes SKIN LESIONS,129,39,,140,62,causes,0.596284793999944,902348-FS1-4,Skin biopsies from eight patients with DRUG INDUCED DERMATITIS have been compared with skin biopsies from 16 patients developing SKIN LESIONS (acute graft versus host reaction and/or drug induced reaction) after bone marrow transplantation.,SKIN LESIONS,DRUG INDUCED DERMATITIS,RO-disease_has_primary_anatomic_site
504170031,7/17/2014 11:11:01,,1325169622,7/17/2014 11:10:49,instagc,0.6556,23149109,USA,NC,Durham,75.189.206.205,SCIATICA causes PAIN,57,63,,60,71,causes,0.56980288229819,904678-FS1-4,I stay in bed most of the time because of my back or leg PAIN (SCIATICA,PAIN,SCIATICA,RO-has_definitional_manifestation
504170031,7/17/2014 11:11:50,,1325170392,7/17/2014 11:11:22,clixsense,0.8958,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,SCIATICA causes PAIN,57,63,,60,71,causes,0.56980288229819,904678-FS1-4,I stay in bed most of the time because of my back or leg PAIN (SCIATICA,PAIN,SCIATICA,RO-has_definitional_manifestation
504170031,7/17/2014 11:21:57,,1325178409,7/17/2014 11:21:25,prodege,0.6181,15439740,AUS,02,Jannali,27.96.208.89,no_relation,57,63,,60,71,causes,0.56980288229819,904678-FS1-4,I stay in bed most of the time because of my back or leg PAIN (SCIATICA,PAIN,SCIATICA,RO-has_definitional_manifestation
504170031,7/17/2014 11:53:59,,1325202876,7/17/2014 11:53:36,instagc,0.6653,13763729,USA,"","",75.182.89.225,no_relation,57,63,,60,71,causes,0.56980288229819,904678-FS1-4,I stay in bed most of the time because of my back or leg PAIN (SCIATICA,PAIN,SCIATICA,RO-has_definitional_manifestation
504170031,7/17/2014 13:59:56,,1325310594,7/17/2014 13:59:41,clixsense,0.6744,6579377,CAN,BC,Richmond,174.6.142.227,SCIATICA causes PAIN,57,63,,60,71,causes,0.56980288229819,904678-FS1-4,I stay in bed most of the time because of my back or leg PAIN (SCIATICA,PAIN,SCIATICA,RO-has_definitional_manifestation
504170031,7/17/2014 14:03:47,,1325314442,7/17/2014 14:03:36,clixsense,0.5901,15189335,GBR,T5,Aberdeen,90.218.222.164,SCIATICA causes PAIN,57,63,,60,71,causes,0.56980288229819,904678-FS1-4,I stay in bed most of the time because of my back or leg PAIN (SCIATICA,PAIN,SCIATICA,RO-has_definitional_manifestation
504170031,7/17/2014 14:05:12,,1325315724,7/17/2014 14:04:48,neodev,0.5669,18339121,USA,SC,Sumter,173.93.188.194,PAIN causes SCIATICA,57,63,,60,71,causes,0.56980288229819,904678-FS1-4,I stay in bed most of the time because of my back or leg PAIN (SCIATICA,PAIN,SCIATICA,RO-has_definitional_manifestation
504170032,7/17/2014 10:23:12,,1325132556,7/17/2014 10:23:03,clixsense,1.0,27793793,GBR,C5,Chester,151.230.27.155,CANDIDA treats CANDIDEMIA,84,13,,90,23,treats,0.351123441588392,903897-FS1-2,Treatment of CANDIDEMIA is more complicated because of the changing epidemiology of CANDIDA and introduction of newer antifungal agents.,CANDIDA,CANDIDEMIA,RO-has_causative_agent
504170032,7/17/2014 10:28:01,,1325136323,7/17/2014 10:27:45,instagc,0.9583,24252915,GBR,B7,Bristol,77.98.139.82,no_relation,84,13,,90,23,treats,0.351123441588392,903897-FS1-2,Treatment of CANDIDEMIA is more complicated because of the changing epidemiology of CANDIDA and introduction of newer antifungal agents.,CANDIDA,CANDIDEMIA,RO-has_causative_agent
504170032,7/17/2014 10:34:22,,1325141666,7/17/2014 10:33:52,clixsense,0.8472,19162475,GBR,M3,Frome,82.33.126.30,CANDIDA treats CANDIDEMIA,84,13,,90,23,treats,0.351123441588392,903897-FS1-2,Treatment of CANDIDEMIA is more complicated because of the changing epidemiology of CANDIDA and introduction of newer antifungal agents.,CANDIDA,CANDIDEMIA,RO-has_causative_agent
504170032,7/17/2014 10:40:06,,1325146146,7/17/2014 10:39:48,clixsense,0.8958,19803139,NLD,06,Veldhoven,212.61.84.196,CANDIDA treats CANDIDEMIA,84,13,,90,23,treats,0.351123441588392,903897-FS1-2,Treatment of CANDIDEMIA is more complicated because of the changing epidemiology of CANDIDA and introduction of newer antifungal agents.,CANDIDA,CANDIDEMIA,RO-has_causative_agent
504170032,7/17/2014 11:10:37,,1325169295,7/17/2014 11:10:26,instagc,0.6556,23149109,USA,NC,Durham,75.189.206.205,CANDIDEMIA treats CANDIDA,84,13,,90,23,treats,0.351123441588392,903897-FS1-2,Treatment of CANDIDEMIA is more complicated because of the changing epidemiology of CANDIDA and introduction of newer antifungal agents.,CANDIDA,CANDIDEMIA,RO-has_causative_agent
504170032,7/17/2014 11:53:34,,1325202666,7/17/2014 11:53:20,instagc,0.6653,13763729,USA,"","",75.182.89.225,no_relation,84,13,,90,23,treats,0.351123441588392,903897-FS1-2,Treatment of CANDIDEMIA is more complicated because of the changing epidemiology of CANDIDA and introduction of newer antifungal agents.,CANDIDA,CANDIDEMIA,RO-has_causative_agent
504170032,7/17/2014 12:30:56,,1325230668,7/17/2014 12:30:28,prodege,0.6827,7664351,USA,NY,Cicero,74.111.0.21,CANDIDA treats CANDIDEMIA,84,13,,90,23,treats,0.351123441588392,903897-FS1-2,Treatment of CANDIDEMIA is more complicated because of the changing epidemiology of CANDIDA and introduction of newer antifungal agents.,CANDIDA,CANDIDEMIA,RO-has_causative_agent
504170033,7/17/2014 10:22:21,,1325131950,7/17/2014 10:22:14,clixsense,1.0,27793793,GBR,C5,Chester,151.230.27.155,HODGKIN'S DISEASE treats VINCRISTINE,56,128,,72,139,treats,1,908106-FS1-2,"Seventy six patients with previously untreated advanced HODGKIN'S DISEASE have been treated with the MOPP/ABV (mechlorethamine, VINCRISTINE procarbazine, prednisone/doxorubicin, bleomycin, vincristine) hybrid program.",HODGKIN'S DISEASE,VINCRISTINE,RO-may_treat
504170033,7/17/2014 10:35:21,,1325142602,7/17/2014 10:35:15,clixsense,0.8472,19162475,GBR,M3,Frome,82.33.126.30,VINCRISTINE treats HODGKIN'S DISEASE,56,128,,72,139,treats,1,908106-FS1-2,"Seventy six patients with previously untreated advanced HODGKIN'S DISEASE have been treated with the MOPP/ABV (mechlorethamine, VINCRISTINE procarbazine, prednisone/doxorubicin, bleomycin, vincristine) hybrid program.",HODGKIN'S DISEASE,VINCRISTINE,RO-may_treat
504170033,7/17/2014 11:12:58,,1325171433,7/17/2014 11:12:42,clixsense,0.8958,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,VINCRISTINE treats HODGKIN'S DISEASE,56,128,,72,139,treats,1,908106-FS1-2,"Seventy six patients with previously untreated advanced HODGKIN'S DISEASE have been treated with the MOPP/ABV (mechlorethamine, VINCRISTINE procarbazine, prednisone/doxorubicin, bleomycin, vincristine) hybrid program.",HODGKIN'S DISEASE,VINCRISTINE,RO-may_treat
504170033,7/17/2014 11:22:15,,1325178657,7/17/2014 11:21:59,prodege,0.6181,15439740,AUS,02,Jannali,27.96.208.89,VINCRISTINE treats HODGKIN'S DISEASE,56,128,,72,139,treats,1,908106-FS1-2,"Seventy six patients with previously untreated advanced HODGKIN'S DISEASE have been treated with the MOPP/ABV (mechlorethamine, VINCRISTINE procarbazine, prednisone/doxorubicin, bleomycin, vincristine) hybrid program.",HODGKIN'S DISEASE,VINCRISTINE,RO-may_treat
504170033,7/17/2014 11:51:39,,1325201239,7/17/2014 11:51:29,gifthulk,0.8375,21916793,GBR,"","",87.115.178.12,VINCRISTINE treats HODGKIN'S DISEASE,56,128,,72,139,treats,1,908106-FS1-2,"Seventy six patients with previously untreated advanced HODGKIN'S DISEASE have been treated with the MOPP/ABV (mechlorethamine, VINCRISTINE procarbazine, prednisone/doxorubicin, bleomycin, vincristine) hybrid program.",HODGKIN'S DISEASE,VINCRISTINE,RO-may_treat
504170033,7/17/2014 13:11:32,,1325264648,7/17/2014 13:11:19,neodev,0.7137,21515166,NLD,11,Nootdorp,83.86.58.179,VINCRISTINE treats HODGKIN'S DISEASE,56,128,,72,139,treats,1,908106-FS1-2,"Seventy six patients with previously untreated advanced HODGKIN'S DISEASE have been treated with the MOPP/ABV (mechlorethamine, VINCRISTINE procarbazine, prednisone/doxorubicin, bleomycin, vincristine) hybrid program.",HODGKIN'S DISEASE,VINCRISTINE,RO-may_treat
504170033,7/17/2014 14:00:34,,1325311249,7/17/2014 14:00:17,clixsense,0.6744,6579377,CAN,BC,Richmond,174.6.142.227,VINCRISTINE treats HODGKIN'S DISEASE,56,128,,72,139,treats,1,908106-FS1-2,"Seventy six patients with previously untreated advanced HODGKIN'S DISEASE have been treated with the MOPP/ABV (mechlorethamine, VINCRISTINE procarbazine, prednisone/doxorubicin, bleomycin, vincristine) hybrid program.",HODGKIN'S DISEASE,VINCRISTINE,RO-may_treat
504170034,7/17/2014 10:22:21,,1325131953,7/17/2014 10:22:14,clixsense,1.0,27793793,GBR,C5,Chester,151.230.27.155,PRE EXISTING EPILEPSY causes SEIZURES,124,85,,131,106,causes,0.949425326555083,904689-FS1-4,There was no reported increase in seizures after starting melatonin in children with PRE EXISTING EPILEPSY and no new onset SEIZURES.,SEIZURES,PRE EXISTING EPILEPSY,RO-has_definitional_manifestation
504170034,7/17/2014 10:27:05,,1325135423,7/17/2014 10:26:45,instagc,0.9583,24252915,GBR,B7,Bristol,77.98.139.82,PRE EXISTING EPILEPSY causes SEIZURES,124,85,,131,106,causes,0.949425326555083,904689-FS1-4,There was no reported increase in seizures after starting melatonin in children with PRE EXISTING EPILEPSY and no new onset SEIZURES.,SEIZURES,PRE EXISTING EPILEPSY,RO-has_definitional_manifestation
504170034,7/17/2014 10:40:06,,1325146166,7/17/2014 10:39:48,clixsense,0.8958,19803139,NLD,06,Veldhoven,212.61.84.196,PRE EXISTING EPILEPSY causes SEIZURES,124,85,,131,106,causes,0.949425326555083,904689-FS1-4,There was no reported increase in seizures after starting melatonin in children with PRE EXISTING EPILEPSY and no new onset SEIZURES.,SEIZURES,PRE EXISTING EPILEPSY,RO-has_definitional_manifestation
504170034,7/17/2014 11:52:33,,1325201926,7/17/2014 11:52:15,gifthulk,0.8375,21916793,GBR,"","",87.115.178.12,PRE EXISTING EPILEPSY causes SEIZURES,124,85,,131,106,causes,0.949425326555083,904689-FS1-4,There was no reported increase in seizures after starting melatonin in children with PRE EXISTING EPILEPSY and no new onset SEIZURES.,SEIZURES,PRE EXISTING EPILEPSY,RO-has_definitional_manifestation
504170034,7/17/2014 12:15:27,,1325218493,7/17/2014 12:15:09,elite,0.6262,28503042,USA,NJ,Woodbridge,54.191.150.115,PRE EXISTING EPILEPSY causes SEIZURES,124,85,,131,106,causes,0.949425326555083,904689-FS1-4,There was no reported increase in seizures after starting melatonin in children with PRE EXISTING EPILEPSY and no new onset SEIZURES.,SEIZURES,PRE EXISTING EPILEPSY,RO-has_definitional_manifestation
504170034,7/17/2014 12:23:36,,1325224795,7/17/2014 12:22:59,prodege,0.6909,24945126,GBR,F6,Romford,82.12.220.44,no_relation,124,85,,131,106,causes,0.949425326555083,904689-FS1-4,There was no reported increase in seizures after starting melatonin in children with PRE EXISTING EPILEPSY and no new onset SEIZURES.,SEIZURES,PRE EXISTING EPILEPSY,RO-has_definitional_manifestation
504170034,7/17/2014 14:11:05,,1325320723,7/17/2014 14:10:47,clixsense,0.7183,27871219,NLD,07,Amsterdam,87.210.207.223,PRE EXISTING EPILEPSY causes SEIZURES,124,85,,131,106,causes,0.949425326555083,904689-FS1-4,There was no reported increase in seizures after starting melatonin in children with PRE EXISTING EPILEPSY and no new onset SEIZURES.,SEIZURES,PRE EXISTING EPILEPSY,RO-has_definitional_manifestation
504170035,7/17/2014 10:26:44,,1325135258,7/17/2014 10:26:20,instagc,0.9583,24252915,GBR,B7,Bristol,77.98.139.82,no_relation,0,0,,7,20,is location of,0.750478774386456,903841-FS1-9,MECONIUM PERITONITIS occasionally occurs as a localized collection of MECONIUM contained in a cyst made of fibrous granulation tissue.,MECONIUM,MECONIUM PERITONITIS,RO-has_causative_agent
504170035,7/17/2014 11:11:01,,1325169610,7/17/2014 11:10:49,instagc,0.6556,23149109,USA,NC,Durham,75.189.206.205,MECONIUM is location of MECONIUM PERITONITIS,0,0,,7,20,is location of,0.750478774386456,903841-FS1-9,MECONIUM PERITONITIS occasionally occurs as a localized collection of MECONIUM contained in a cyst made of fibrous granulation tissue.,MECONIUM,MECONIUM PERITONITIS,RO-has_causative_agent
504170035,7/17/2014 11:21:24,,1325177945,7/17/2014 11:21:10,prodege,0.6181,15439740,AUS,02,Jannali,27.96.208.89,no_relation,0,0,,7,20,is location of,0.750478774386456,903841-FS1-9,MECONIUM PERITONITIS occasionally occurs as a localized collection of MECONIUM contained in a cyst made of fibrous granulation tissue.,MECONIUM,MECONIUM PERITONITIS,RO-has_causative_agent
504170035,7/17/2014 11:54:32,,1325203216,7/17/2014 11:54:01,instagc,0.6653,13763729,USA,"","",75.182.89.225,no_relation,0,0,,7,20,is location of,0.750478774386456,903841-FS1-9,MECONIUM PERITONITIS occasionally occurs as a localized collection of MECONIUM contained in a cyst made of fibrous granulation tissue.,MECONIUM,MECONIUM PERITONITIS,RO-has_causative_agent
504170035,7/17/2014 12:15:50,,1325218832,7/17/2014 12:15:28,elite,0.6262,28503042,USA,NJ,Woodbridge,54.191.150.115,MECONIUM PERITONITIS is location of MECONIUM,0,0,,7,20,is location of,0.750478774386456,903841-FS1-9,MECONIUM PERITONITIS occasionally occurs as a localized collection of MECONIUM contained in a cyst made of fibrous granulation tissue.,MECONIUM,MECONIUM PERITONITIS,RO-has_causative_agent
504170035,7/17/2014 12:54:11,,1325249955,7/17/2014 12:53:54,clixsense,0.7,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,0,0,,7,20,is location of,0.750478774386456,903841-FS1-9,MECONIUM PERITONITIS occasionally occurs as a localized collection of MECONIUM contained in a cyst made of fibrous granulation tissue.,MECONIUM,MECONIUM PERITONITIS,RO-has_causative_agent
504170035,7/17/2014 14:04:07,,1325314733,7/17/2014 14:03:48,clixsense,0.5901,15189335,GBR,T5,Aberdeen,90.218.222.164,no_relation,0,0,,7,20,is location of,0.750478774386456,903841-FS1-9,MECONIUM PERITONITIS occasionally occurs as a localized collection of MECONIUM contained in a cyst made of fibrous granulation tissue.,MECONIUM,MECONIUM PERITONITIS,RO-has_causative_agent
504170036,7/17/2014 11:12:16,,1325170838,7/17/2014 11:11:52,clixsense,0.8958,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,GLUCOSE TESTING treats DIABETES,98,53,,105,68,treats,0.369800130816819,906639-FS1-2,One way to improve the quality of care is to perform GLUCOSE TESTING on patients at high risk for DIABETES and to obtain complete lipid profiles.,DIABETES,GLUCOSE TESTING,RO-may_diagnose
504170036,7/17/2014 11:19:39,,1325176611,7/17/2014 11:19:08,prodege,0.6597,27934334,GBR,"","",86.130.153.15,no_relation,98,53,,105,68,treats,0.369800130816819,906639-FS1-2,One way to improve the quality of care is to perform GLUCOSE TESTING on patients at high risk for DIABETES and to obtain complete lipid profiles.,DIABETES,GLUCOSE TESTING,RO-may_diagnose
504170036,7/17/2014 12:32:09,,1325231608,7/17/2014 12:31:34,prodege,0.6827,7664351,USA,NY,Cicero,74.111.0.21,no_relation,98,53,,105,68,treats,0.369800130816819,906639-FS1-2,One way to improve the quality of care is to perform GLUCOSE TESTING on patients at high risk for DIABETES and to obtain complete lipid profiles.,DIABETES,GLUCOSE TESTING,RO-may_diagnose
504170036,7/17/2014 12:55:30,,1325251035,7/17/2014 12:55:05,clixsense,0.7,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,98,53,,105,68,treats,0.369800130816819,906639-FS1-2,One way to improve the quality of care is to perform GLUCOSE TESTING on patients at high risk for DIABETES and to obtain complete lipid profiles.,DIABETES,GLUCOSE TESTING,RO-may_diagnose
504170036,7/17/2014 14:04:28,,1325315005,7/17/2014 14:04:08,clixsense,0.5901,15189335,GBR,T5,Aberdeen,90.218.222.164,no_relation,98,53,,105,68,treats,0.369800130816819,906639-FS1-2,One way to improve the quality of care is to perform GLUCOSE TESTING on patients at high risk for DIABETES and to obtain complete lipid profiles.,DIABETES,GLUCOSE TESTING,RO-may_diagnose
504170036,7/17/2014 14:06:47,,1325317041,7/17/2014 14:06:29,neodev,0.5669,18339121,USA,SC,Sumter,173.93.188.194,GLUCOSE TESTING treats DIABETES,98,53,,105,68,treats,0.369800130816819,906639-FS1-2,One way to improve the quality of care is to perform GLUCOSE TESTING on patients at high risk for DIABETES and to obtain complete lipid profiles.,DIABETES,GLUCOSE TESTING,RO-may_diagnose
504170036,7/17/2014 14:11:05,,1325320725,7/17/2014 14:10:47,clixsense,0.7183,27871219,NLD,07,Amsterdam,87.210.207.223,GLUCOSE TESTING treats DIABETES,98,53,,105,68,treats,0.369800130816819,906639-FS1-2,One way to improve the quality of care is to perform GLUCOSE TESTING on patients at high risk for DIABETES and to obtain complete lipid profiles.,DIABETES,GLUCOSE TESTING,RO-may_diagnose
504170037,7/17/2014 10:28:17,,1325136583,7/17/2014 10:28:02,instagc,0.9583,24252915,GBR,B7,Bristol,77.98.139.82,no_relation,41,20,,55,28,causes,0.948683298050514,902066-FS1-4,Chemotherapy causes ALOPECIA by damaging HAIR STEM CELLS and hair follicles making the hair brittle and causing scalp hair to break off or fall out.,HAIR STEM CELLS,ALOPECIA,RO-disease_has_primary_anatomic_site
504170037,7/17/2014 11:10:05,,1325168864,7/17/2014 11:09:57,instagc,0.6556,23149109,USA,NC,Durham,75.189.206.205,HAIR STEM CELLS causes ALOPECIA,41,20,,55,28,causes,0.948683298050514,902066-FS1-4,Chemotherapy causes ALOPECIA by damaging HAIR STEM CELLS and hair follicles making the hair brittle and causing scalp hair to break off or fall out.,HAIR STEM CELLS,ALOPECIA,RO-disease_has_primary_anatomic_site
504170037,7/17/2014 11:22:30,,1325178795,7/17/2014 11:22:16,prodege,0.6181,15439740,AUS,02,Jannali,27.96.208.89,no_relation,41,20,,55,28,causes,0.948683298050514,902066-FS1-4,Chemotherapy causes ALOPECIA by damaging HAIR STEM CELLS and hair follicles making the hair brittle and causing scalp hair to break off or fall out.,HAIR STEM CELLS,ALOPECIA,RO-disease_has_primary_anatomic_site
504170037,7/17/2014 11:52:33,,1325201956,7/17/2014 11:52:15,gifthulk,0.8375,21916793,GBR,"","",87.115.178.12,no_relation,41,20,,55,28,causes,0.948683298050514,902066-FS1-4,Chemotherapy causes ALOPECIA by damaging HAIR STEM CELLS and hair follicles making the hair brittle and causing scalp hair to break off or fall out.,HAIR STEM CELLS,ALOPECIA,RO-disease_has_primary_anatomic_site
504170037,7/17/2014 12:23:36,,1325224792,7/17/2014 12:22:59,prodege,0.6909,24945126,GBR,F6,Romford,82.12.220.44,no_relation,41,20,,55,28,causes,0.948683298050514,902066-FS1-4,Chemotherapy causes ALOPECIA by damaging HAIR STEM CELLS and hair follicles making the hair brittle and causing scalp hair to break off or fall out.,HAIR STEM CELLS,ALOPECIA,RO-disease_has_primary_anatomic_site
504170037,7/17/2014 12:55:04,,1325250656,7/17/2014 12:54:52,clixsense,0.7,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,41,20,,55,28,causes,0.948683298050514,902066-FS1-4,Chemotherapy causes ALOPECIA by damaging HAIR STEM CELLS and hair follicles making the hair brittle and causing scalp hair to break off or fall out.,HAIR STEM CELLS,ALOPECIA,RO-disease_has_primary_anatomic_site
504170037,7/17/2014 13:10:24,,1325263585,7/17/2014 13:09:44,neodev,0.7137,21515166,NLD,11,Nootdorp,83.86.58.179,no_relation,41,20,,55,28,causes,0.948683298050514,902066-FS1-4,Chemotherapy causes ALOPECIA by damaging HAIR STEM CELLS and hair follicles making the hair brittle and causing scalp hair to break off or fall out.,HAIR STEM CELLS,ALOPECIA,RO-disease_has_primary_anatomic_site
504170038,7/17/2014 10:22:43,,1325132241,7/17/2014 10:22:32,clixsense,1.0,27793793,GBR,C5,Chester,151.230.27.155,no_relation,131,171,,150,183,causes,0.333333333333333,905786-FS1-4,"The greatest variation from the proteinase K polypeptide is in loop 114 134 and is due to the absence of a disulfide bridge in the P CYCLOPIUM PROTEASE that is present in PROTEINASE K A difference was also observed in the orientation of the histidine in the catalytic triad, though this could be due to the presence of PMSF at the active site.",P CYCLOPIUM PROTEASE,PROTEINASE K,RO-has_ingredient
504170038,7/17/2014 10:45:24,,1325150221,7/17/2014 10:45:02,prodege,0.8333,9525153,CAN,ON,Toronto,65.95.92.180,PROTEINASE K causes P CYCLOPIUM PROTEASE,131,171,,150,183,causes,0.333333333333333,905786-FS1-4,"The greatest variation from the proteinase K polypeptide is in loop 114 134 and is due to the absence of a disulfide bridge in the P CYCLOPIUM PROTEASE that is present in PROTEINASE K A difference was also observed in the orientation of the histidine in the catalytic triad, though this could be due to the presence of PMSF at the active site.",P CYCLOPIUM PROTEASE,PROTEINASE K,RO-has_ingredient
504170038,7/17/2014 11:55:38,,1325203876,7/17/2014 11:55:04,tremorgames,0.7111,24449707,CAN,QC,Laval,96.21.249.72,no_relation,131,171,,150,183,causes,0.333333333333333,905786-FS1-4,"The greatest variation from the proteinase K polypeptide is in loop 114 134 and is due to the absence of a disulfide bridge in the P CYCLOPIUM PROTEASE that is present in PROTEINASE K A difference was also observed in the orientation of the histidine in the catalytic triad, though this could be due to the presence of PMSF at the active site.",P CYCLOPIUM PROTEASE,PROTEINASE K,RO-has_ingredient
504170038,7/17/2014 13:10:49,,1325263928,7/17/2014 13:10:25,neodev,0.7137,21515166,NLD,11,Nootdorp,83.86.58.179,PROTEINASE K causes P CYCLOPIUM PROTEASE,131,171,,150,183,causes,0.333333333333333,905786-FS1-4,"The greatest variation from the proteinase K polypeptide is in loop 114 134 and is due to the absence of a disulfide bridge in the P CYCLOPIUM PROTEASE that is present in PROTEINASE K A difference was also observed in the orientation of the histidine in the catalytic triad, though this could be due to the presence of PMSF at the active site.",P CYCLOPIUM PROTEASE,PROTEINASE K,RO-has_ingredient
504170038,7/17/2014 14:32:24,,1325340326,7/17/2014 14:32:13,clixsense,0.4918,20614047,USA,MO,Maryville,174.32.162.147,PROTEINASE K causes P CYCLOPIUM PROTEASE,131,171,,150,183,causes,0.333333333333333,905786-FS1-4,"The greatest variation from the proteinase K polypeptide is in loop 114 134 and is due to the absence of a disulfide bridge in the P CYCLOPIUM PROTEASE that is present in PROTEINASE K A difference was also observed in the orientation of the histidine in the catalytic triad, though this could be due to the presence of PMSF at the active site.",P CYCLOPIUM PROTEASE,PROTEINASE K,RO-has_ingredient
504170038,7/17/2014 14:47:10,,1325353208,7/17/2014 14:46:08,clixsense,0.2,11764504,GBR,M5,Southend-on-sea,92.232.81.238,no_relation,131,171,,150,183,causes,0.333333333333333,905786-FS1-4,"The greatest variation from the proteinase K polypeptide is in loop 114 134 and is due to the absence of a disulfide bridge in the P CYCLOPIUM PROTEASE that is present in PROTEINASE K A difference was also observed in the orientation of the histidine in the catalytic triad, though this could be due to the presence of PMSF at the active site.",P CYCLOPIUM PROTEASE,PROTEINASE K,RO-has_ingredient
504170038,7/17/2014 15:06:13,,1325370856,7/17/2014 15:05:43,elite,0.534,28276268,USA,MI,Taylor,67.149.247.166,P CYCLOPIUM PROTEASE causes PROTEINASE K,131,171,,150,183,causes,0.333333333333333,905786-FS1-4,"The greatest variation from the proteinase K polypeptide is in loop 114 134 and is due to the absence of a disulfide bridge in the P CYCLOPIUM PROTEASE that is present in PROTEINASE K A difference was also observed in the orientation of the histidine in the catalytic triad, though this could be due to the presence of PMSF at the active site.",P CYCLOPIUM PROTEASE,PROTEINASE K,RO-has_ingredient
504170039,7/17/2014 10:34:57,,1325142165,7/17/2014 10:34:51,clixsense,0.8472,19162475,GBR,M3,Frome,82.33.126.30,ATOPIC DERMATITIS diagnosed by ATOPIC WINTER FEET,150,171,,166,189,diagnosed by,0.363803437554499,900231-FS1-13,When comparing 1% hydrocortisone in a stabilized 10% urea cream with 0.1% betamethasone 17 valerate cream in a double blind study on 49 patients with ATOPIC DERMATITIS or ATOPIC WINTER FEET betamethasone cream was found to be the most potent.,ATOPIC DERMATITIS,ATOPIC WINTER FEET,RO-cause_of
504170039,7/17/2014 11:11:50,,1325170395,7/17/2014 11:11:22,clixsense,0.8958,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,ATOPIC DERMATITIS diagnosed by ATOPIC WINTER FEET,150,171,,166,189,diagnosed by,0.363803437554499,900231-FS1-13,When comparing 1% hydrocortisone in a stabilized 10% urea cream with 0.1% betamethasone 17 valerate cream in a double blind study on 49 patients with ATOPIC DERMATITIS or ATOPIC WINTER FEET betamethasone cream was found to be the most potent.,ATOPIC DERMATITIS,ATOPIC WINTER FEET,RO-cause_of
504170039,7/17/2014 11:26:58,,1325181781,7/17/2014 11:26:17,fusioncash,0.5583,7012325,USA,CT,Stamford,24.185.182.15,no_relation,150,171,,166,189,diagnosed by,0.363803437554499,900231-FS1-13,When comparing 1% hydrocortisone in a stabilized 10% urea cream with 0.1% betamethasone 17 valerate cream in a double blind study on 49 patients with ATOPIC DERMATITIS or ATOPIC WINTER FEET betamethasone cream was found to be the most potent.,ATOPIC DERMATITIS,ATOPIC WINTER FEET,RO-cause_of
504170039,7/17/2014 11:54:51,,1325203398,7/17/2014 11:54:33,instagc,0.6653,13763729,USA,"","",75.182.89.225,no_relation,150,171,,166,189,diagnosed by,0.363803437554499,900231-FS1-13,When comparing 1% hydrocortisone in a stabilized 10% urea cream with 0.1% betamethasone 17 valerate cream in a double blind study on 49 patients with ATOPIC DERMATITIS or ATOPIC WINTER FEET betamethasone cream was found to be the most potent.,ATOPIC DERMATITIS,ATOPIC WINTER FEET,RO-cause_of
504170039,7/17/2014 12:14:49,,1325218056,7/17/2014 12:14:14,elite,0.6262,28503042,USA,NJ,Woodbridge,54.191.150.115,no_relation,150,171,,166,189,diagnosed by,0.363803437554499,900231-FS1-13,When comparing 1% hydrocortisone in a stabilized 10% urea cream with 0.1% betamethasone 17 valerate cream in a double blind study on 49 patients with ATOPIC DERMATITIS or ATOPIC WINTER FEET betamethasone cream was found to be the most potent.,ATOPIC DERMATITIS,ATOPIC WINTER FEET,RO-cause_of
504170039,7/17/2014 13:24:12,,1325275543,7/17/2014 13:23:51,prodege,0.6909,24945126,GBR,F6,Romford,82.12.220.44,no_relation,150,171,,166,189,diagnosed by,0.363803437554499,900231-FS1-13,When comparing 1% hydrocortisone in a stabilized 10% urea cream with 0.1% betamethasone 17 valerate cream in a double blind study on 49 patients with ATOPIC DERMATITIS or ATOPIC WINTER FEET betamethasone cream was found to be the most potent.,ATOPIC DERMATITIS,ATOPIC WINTER FEET,RO-cause_of
504170039,7/17/2014 13:40:42,,1325292777,7/17/2014 13:40:22,prodege,0.5202,28039757,GBR,L8,Southport,109.155.158.54,no_relation,150,171,,166,189,diagnosed by,0.363803437554499,900231-FS1-13,When comparing 1% hydrocortisone in a stabilized 10% urea cream with 0.1% betamethasone 17 valerate cream in a double blind study on 49 patients with ATOPIC DERMATITIS or ATOPIC WINTER FEET betamethasone cream was found to be the most potent.,ATOPIC DERMATITIS,ATOPIC WINTER FEET,RO-cause_of
504170040,7/17/2014 10:34:57,,1325142164,7/17/2014 10:34:51,clixsense,0.8472,19162475,GBR,M3,Frome,82.33.126.30,LIPOSOMAL AMPHOTERICIN B treats DRUG RESISTANT VISCERAL LEISHMANIASIS,70,152,,106,176,treats,0.979957887012223,908300-FS1-2,"This report is of the successful treatment of a patient with multiply DRUG RESISTANT VISCERAL LEISHMANIASIS with a commercially prepared formulation of LIPOSOMAL AMPHOTERICIN B (L AmB) ('AmBisome', Vestar, San Dimas, California, USA.",DRUG RESISTANT VISCERAL LEISHMANIASIS,LIPOSOMAL AMPHOTERICIN B,RO-may_treat
504170040,7/17/2014 10:47:13,,1325151616,7/17/2014 10:46:40,prodege,0.8333,9525153,CAN,ON,Toronto,65.95.92.180,LIPOSOMAL AMPHOTERICIN B treats DRUG RESISTANT VISCERAL LEISHMANIASIS,70,152,,106,176,treats,0.979957887012223,908300-FS1-2,"This report is of the successful treatment of a patient with multiply DRUG RESISTANT VISCERAL LEISHMANIASIS with a commercially prepared formulation of LIPOSOMAL AMPHOTERICIN B (L AmB) ('AmBisome', Vestar, San Dimas, California, USA.",DRUG RESISTANT VISCERAL LEISHMANIASIS,LIPOSOMAL AMPHOTERICIN B,RO-may_treat
504170040,7/17/2014 11:10:48,,1325169433,7/17/2014 11:10:38,instagc,0.6556,23149109,USA,NC,Durham,75.189.206.205,LIPOSOMAL AMPHOTERICIN B treats DRUG RESISTANT VISCERAL LEISHMANIASIS,70,152,,106,176,treats,0.979957887012223,908300-FS1-2,"This report is of the successful treatment of a patient with multiply DRUG RESISTANT VISCERAL LEISHMANIASIS with a commercially prepared formulation of LIPOSOMAL AMPHOTERICIN B (L AmB) ('AmBisome', Vestar, San Dimas, California, USA.",DRUG RESISTANT VISCERAL LEISHMANIASIS,LIPOSOMAL AMPHOTERICIN B,RO-may_treat
504170040,7/17/2014 11:51:28,,1325201135,7/17/2014 11:51:18,gifthulk,0.8375,21916793,GBR,"","",87.115.178.12,LIPOSOMAL AMPHOTERICIN B treats DRUG RESISTANT VISCERAL LEISHMANIASIS,70,152,,106,176,treats,0.979957887012223,908300-FS1-2,"This report is of the successful treatment of a patient with multiply DRUG RESISTANT VISCERAL LEISHMANIASIS with a commercially prepared formulation of LIPOSOMAL AMPHOTERICIN B (L AmB) ('AmBisome', Vestar, San Dimas, California, USA.",DRUG RESISTANT VISCERAL LEISHMANIASIS,LIPOSOMAL AMPHOTERICIN B,RO-may_treat
504170040,7/17/2014 12:32:09,,1325231609,7/17/2014 12:31:34,prodege,0.6827,7664351,USA,NY,Cicero,74.111.0.21,LIPOSOMAL AMPHOTERICIN B treats DRUG RESISTANT VISCERAL LEISHMANIASIS,70,152,,106,176,treats,0.979957887012223,908300-FS1-2,"This report is of the successful treatment of a patient with multiply DRUG RESISTANT VISCERAL LEISHMANIASIS with a commercially prepared formulation of LIPOSOMAL AMPHOTERICIN B (L AmB) ('AmBisome', Vestar, San Dimas, California, USA.",DRUG RESISTANT VISCERAL LEISHMANIASIS,LIPOSOMAL AMPHOTERICIN B,RO-may_treat
504170040,7/17/2014 12:54:23,,1325250090,7/17/2014 12:54:12,clixsense,0.7,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,70,152,,106,176,treats,0.979957887012223,908300-FS1-2,"This report is of the successful treatment of a patient with multiply DRUG RESISTANT VISCERAL LEISHMANIASIS with a commercially prepared formulation of LIPOSOMAL AMPHOTERICIN B (L AmB) ('AmBisome', Vestar, San Dimas, California, USA.",DRUG RESISTANT VISCERAL LEISHMANIASIS,LIPOSOMAL AMPHOTERICIN B,RO-may_treat
504170040,7/17/2014 13:11:17,,1325264370,7/17/2014 13:10:50,neodev,0.7137,21515166,NLD,11,Nootdorp,83.86.58.179,LIPOSOMAL AMPHOTERICIN B treats DRUG RESISTANT VISCERAL LEISHMANIASIS,70,152,,106,176,treats,0.979957887012223,908300-FS1-2,"This report is of the successful treatment of a patient with multiply DRUG RESISTANT VISCERAL LEISHMANIASIS with a commercially prepared formulation of LIPOSOMAL AMPHOTERICIN B (L AmB) ('AmBisome', Vestar, San Dimas, California, USA.",DRUG RESISTANT VISCERAL LEISHMANIASIS,LIPOSOMAL AMPHOTERICIN B,RO-may_treat
504170041,7/17/2014 10:22:31,,1325132104,7/17/2014 10:22:22,clixsense,1.0,27793793,GBR,C5,Chester,151.230.27.155,INFECTIOUS MONONUCLEOSIS causes LYMPHADENOPATHY,9,46,,23,70,causes,1,901900-FS1-4,"Painless LYMPHADENOPATHY can also result from INFECTIOUS MONONUCLEOSIS toxoplasmosis, cytomegalovirus, or leukemia.",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
504170041,7/17/2014 11:54:11,,1325203036,7/17/2014 11:54:01,gifthulk,0.8375,21916793,GBR,"","",87.115.178.12,INFECTIOUS MONONUCLEOSIS causes LYMPHADENOPATHY,9,46,,23,70,causes,1,901900-FS1-4,"Painless LYMPHADENOPATHY can also result from INFECTIOUS MONONUCLEOSIS toxoplasmosis, cytomegalovirus, or leukemia.",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
504170041,7/17/2014 12:14:13,,1325217510,7/17/2014 12:13:57,elite,0.6262,28503042,USA,NJ,Woodbridge,54.191.150.115,INFECTIOUS MONONUCLEOSIS causes LYMPHADENOPATHY,9,46,,23,70,causes,1,901900-FS1-4,"Painless LYMPHADENOPATHY can also result from INFECTIOUS MONONUCLEOSIS toxoplasmosis, cytomegalovirus, or leukemia.",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
504170041,7/17/2014 12:54:50,,1325250495,7/17/2014 12:54:38,clixsense,0.7,16827630,GBR,A7,Birmingham,86.146.169.103,INFECTIOUS MONONUCLEOSIS causes LYMPHADENOPATHY,9,46,,23,70,causes,1,901900-FS1-4,"Painless LYMPHADENOPATHY can also result from INFECTIOUS MONONUCLEOSIS toxoplasmosis, cytomegalovirus, or leukemia.",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
504170041,7/17/2014 13:11:32,,1325264602,7/17/2014 13:11:19,neodev,0.7137,21515166,NLD,11,Nootdorp,83.86.58.179,INFECTIOUS MONONUCLEOSIS causes LYMPHADENOPATHY,9,46,,23,70,causes,1,901900-FS1-4,"Painless LYMPHADENOPATHY can also result from INFECTIOUS MONONUCLEOSIS toxoplasmosis, cytomegalovirus, or leukemia.",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
504170041,7/17/2014 13:37:53,,1325290058,7/17/2014 13:37:35,clixsense,0.6825,6574199,USA,TX,San Antonio,207.230.144.242,INFECTIOUS MONONUCLEOSIS causes LYMPHADENOPATHY,9,46,,23,70,causes,1,901900-FS1-4,"Painless LYMPHADENOPATHY can also result from INFECTIOUS MONONUCLEOSIS toxoplasmosis, cytomegalovirus, or leukemia.",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
504170041,7/17/2014 13:59:56,,1325310607,7/17/2014 13:59:41,clixsense,0.6744,6579377,CAN,BC,Richmond,174.6.142.227,INFECTIOUS MONONUCLEOSIS causes LYMPHADENOPATHY,9,46,,23,70,causes,1,901900-FS1-4,"Painless LYMPHADENOPATHY can also result from INFECTIOUS MONONUCLEOSIS toxoplasmosis, cytomegalovirus, or leukemia.",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
504170042,7/17/2014 10:22:53,,1325132384,7/17/2014 10:22:44,clixsense,1.0,27793793,GBR,C5,Chester,151.230.27.155,HAIR STEM CELLS is location of ALOPECIA,41,20,,55,28,is location of,0.316227766016838,902066-FS1-9,Chemotherapy causes ALOPECIA by damaging HAIR STEM CELLS and hair follicles making the hair brittle and causing scalp hair to break off or fall out.,HAIR STEM CELLS,ALOPECIA,RO-disease_has_primary_anatomic_site
504170042,7/17/2014 11:10:37,,1325169296,7/17/2014 11:10:26,instagc,0.6556,23149109,USA,NC,Durham,75.189.206.205,HAIR STEM CELLS is location of ALOPECIA,41,20,,55,28,is location of,0.316227766016838,902066-FS1-9,Chemotherapy causes ALOPECIA by damaging HAIR STEM CELLS and hair follicles making the hair brittle and causing scalp hair to break off or fall out.,HAIR STEM CELLS,ALOPECIA,RO-disease_has_primary_anatomic_site
504170042,7/17/2014 11:18:35,,1325175898,7/17/2014 11:17:59,prodege,0.6597,27934334,GBR,"","",86.130.153.15,HAIR STEM CELLS is location of ALOPECIA,41,20,,55,28,is location of,0.316227766016838,902066-FS1-9,Chemotherapy causes ALOPECIA by damaging HAIR STEM CELLS and hair follicles making the hair brittle and causing scalp hair to break off or fall out.,HAIR STEM CELLS,ALOPECIA,RO-disease_has_primary_anatomic_site
504170042,7/17/2014 11:25:40,,1325180926,7/17/2014 11:25:01,fusioncash,0.5583,7012325,USA,CT,Stamford,24.185.182.15,no_relation,41,20,,55,28,is location of,0.316227766016838,902066-FS1-9,Chemotherapy causes ALOPECIA by damaging HAIR STEM CELLS and hair follicles making the hair brittle and causing scalp hair to break off or fall out.,HAIR STEM CELLS,ALOPECIA,RO-disease_has_primary_anatomic_site
504170042,7/17/2014 11:52:58,,1325202209,7/17/2014 11:52:46,instagc,0.6653,13763729,USA,"","",75.182.89.225,HAIR STEM CELLS is location of ALOPECIA,41,20,,55,28,is location of,0.316227766016838,902066-FS1-9,Chemotherapy causes ALOPECIA by damaging HAIR STEM CELLS and hair follicles making the hair brittle and causing scalp hair to break off or fall out.,HAIR STEM CELLS,ALOPECIA,RO-disease_has_primary_anatomic_site
504170042,7/17/2014 13:38:34,,1325290686,7/17/2014 13:37:54,clixsense,0.6825,6574199,USA,TX,San Antonio,207.230.144.242,HAIR STEM CELLS is location of ALOPECIA,41,20,,55,28,is location of,0.316227766016838,902066-FS1-9,Chemotherapy causes ALOPECIA by damaging HAIR STEM CELLS and hair follicles making the hair brittle and causing scalp hair to break off or fall out.,HAIR STEM CELLS,ALOPECIA,RO-disease_has_primary_anatomic_site
504170042,7/17/2014 14:00:16,,1325310914,7/17/2014 13:59:57,clixsense,0.6744,6579377,CAN,BC,Richmond,174.6.142.227,no_relation,41,20,,55,28,is location of,0.316227766016838,902066-FS1-9,Chemotherapy causes ALOPECIA by damaging HAIR STEM CELLS and hair follicles making the hair brittle and causing scalp hair to break off or fall out.,HAIR STEM CELLS,ALOPECIA,RO-disease_has_primary_anatomic_site
504170043,7/17/2014 10:27:22,,1325135633,7/17/2014 10:27:06,instagc,0.9583,24252915,GBR,B7,Bristol,77.98.139.82,no_relation,106,84,,121,96,causes,0.615457454896664,906704-FS1-4,"177 ,   a  Sudden and marked reduction in BP following parenteral administration of PHENTOLAMINE suggests PHEOCHROMOCYTOMA;  a   however, false negative and false positive responses are frequent.",PHEOCHROMOCYTOMA,PHENTOLAMINE,RO-may_diagnose
504170043,7/17/2014 10:46:14,,1325150877,7/17/2014 10:45:39,prodege,0.8333,9525153,CAN,ON,Toronto,65.95.92.180,PHENTOLAMINE causes PHEOCHROMOCYTOMA,106,84,,121,96,causes,0.615457454896664,906704-FS1-4,"177 ,   a  Sudden and marked reduction in BP following parenteral administration of PHENTOLAMINE suggests PHEOCHROMOCYTOMA;  a   however, false negative and false positive responses are frequent.",PHEOCHROMOCYTOMA,PHENTOLAMINE,RO-may_diagnose
504170043,7/17/2014 11:18:35,,1325175900,7/17/2014 11:17:59,prodege,0.6597,27934334,GBR,"","",86.130.153.15,no_relation,106,84,,121,96,causes,0.615457454896664,906704-FS1-4,"177 ,   a  Sudden and marked reduction in BP following parenteral administration of PHENTOLAMINE suggests PHEOCHROMOCYTOMA;  a   however, false negative and false positive responses are frequent.",PHEOCHROMOCYTOMA,PHENTOLAMINE,RO-may_diagnose
504170043,7/17/2014 11:27:16,,1325182005,7/17/2014 11:26:59,fusioncash,0.5583,7012325,USA,CT,Stamford,24.185.182.15,no_relation,106,84,,121,96,causes,0.615457454896664,906704-FS1-4,"177 ,   a  Sudden and marked reduction in BP following parenteral administration of PHENTOLAMINE suggests PHEOCHROMOCYTOMA;  a   however, false negative and false positive responses are frequent.",PHEOCHROMOCYTOMA,PHENTOLAMINE,RO-may_diagnose
504170043,7/17/2014 11:53:19,,1325202476,7/17/2014 11:52:59,instagc,0.6653,13763729,USA,"","",75.182.89.225,no_relation,106,84,,121,96,causes,0.615457454896664,906704-FS1-4,"177 ,   a  Sudden and marked reduction in BP following parenteral administration of PHENTOLAMINE suggests PHEOCHROMOCYTOMA;  a   however, false negative and false positive responses are frequent.",PHEOCHROMOCYTOMA,PHENTOLAMINE,RO-may_diagnose
504170043,7/17/2014 13:39:26,,1325291615,7/17/2014 13:39:06,prodege,0.5202,28039757,GBR,L8,Southport,109.155.158.54,no_relation,106,84,,121,96,causes,0.615457454896664,906704-FS1-4,"177 ,   a  Sudden and marked reduction in BP following parenteral administration of PHENTOLAMINE suggests PHEOCHROMOCYTOMA;  a   however, false negative and false positive responses are frequent.",PHEOCHROMOCYTOMA,PHENTOLAMINE,RO-may_diagnose
504170043,7/17/2014 13:40:04,,1325292185,7/17/2014 13:39:26,clixsense,0.6825,6574199,USA,TX,San Antonio,207.230.144.242,PHENTOLAMINE causes PHEOCHROMOCYTOMA,106,84,,121,96,causes,0.615457454896664,906704-FS1-4,"177 ,   a  Sudden and marked reduction in BP following parenteral administration of PHENTOLAMINE suggests PHEOCHROMOCYTOMA;  a   however, false negative and false positive responses are frequent.",PHEOCHROMOCYTOMA,PHENTOLAMINE,RO-may_diagnose
504170044,7/17/2014 10:23:02,,1325132456,7/17/2014 10:22:55,clixsense,1.0,27793793,GBR,C5,Chester,151.230.27.155,DIABETES diagnosed by GLUCOSE TESTING,98,53,,105,68,diagnosed by,0.924500327042048,906639-FS1-13,One way to improve the quality of care is to perform GLUCOSE TESTING on patients at high risk for DIABETES and to obtain complete lipid profiles.,DIABETES,GLUCOSE TESTING,RO-may_diagnose
504170044,7/17/2014 10:28:01,,1325136312,7/17/2014 10:27:45,instagc,0.9583,24252915,GBR,B7,Bristol,77.98.139.82,DIABETES diagnosed by GLUCOSE TESTING,98,53,,105,68,diagnosed by,0.924500327042048,906639-FS1-13,One way to improve the quality of care is to perform GLUCOSE TESTING on patients at high risk for DIABETES and to obtain complete lipid profiles.,DIABETES,GLUCOSE TESTING,RO-may_diagnose
504170044,7/17/2014 11:10:48,,1325169432,7/17/2014 11:10:38,instagc,0.6556,23149109,USA,NC,Durham,75.189.206.205,DIABETES diagnosed by GLUCOSE TESTING,98,53,,105,68,diagnosed by,0.924500327042048,906639-FS1-13,One way to improve the quality of care is to perform GLUCOSE TESTING on patients at high risk for DIABETES and to obtain complete lipid profiles.,DIABETES,GLUCOSE TESTING,RO-may_diagnose
504170044,7/17/2014 11:21:08,,1325177693,7/17/2014 11:20:47,prodege,0.6181,15439740,AUS,02,Jannali,27.96.208.89,DIABETES diagnosed by GLUCOSE TESTING,98,53,,105,68,diagnosed by,0.924500327042048,906639-FS1-13,One way to improve the quality of care is to perform GLUCOSE TESTING on patients at high risk for DIABETES and to obtain complete lipid profiles.,DIABETES,GLUCOSE TESTING,RO-may_diagnose
504170044,7/17/2014 11:57:55,,1325205416,7/17/2014 11:57:28,tremorgames,0.7111,24449707,CAN,QC,Laval,96.21.249.72,DIABETES diagnosed by GLUCOSE TESTING,98,53,,105,68,diagnosed by,0.924500327042048,906639-FS1-13,One way to improve the quality of care is to perform GLUCOSE TESTING on patients at high risk for DIABETES and to obtain complete lipid profiles.,DIABETES,GLUCOSE TESTING,RO-may_diagnose
504170044,7/17/2014 12:30:28,,1325230245,7/17/2014 12:29:58,prodege,0.6827,7664351,USA,NY,Cicero,74.111.0.21,DIABETES diagnosed by GLUCOSE TESTING,98,53,,105,68,diagnosed by,0.924500327042048,906639-FS1-13,One way to improve the quality of care is to perform GLUCOSE TESTING on patients at high risk for DIABETES and to obtain complete lipid profiles.,DIABETES,GLUCOSE TESTING,RO-may_diagnose
504170044,7/17/2014 13:24:34,,1325275929,7/17/2014 13:24:13,prodege,0.6909,24945126,GBR,F6,Romford,82.12.220.44,DIABETES diagnosed by GLUCOSE TESTING,98,53,,105,68,diagnosed by,0.924500327042048,906639-FS1-13,One way to improve the quality of care is to perform GLUCOSE TESTING on patients at high risk for DIABETES and to obtain complete lipid profiles.,DIABETES,GLUCOSE TESTING,RO-may_diagnose
504170045,7/17/2014 10:47:29,,1325151862,7/17/2014 10:47:15,prodege,0.8333,9525153,CAN,ON,Toronto,65.95.92.180,PHENTOLAMINE treats PHEOCHROMOCYTOMA,106,84,,121,96,treats,0.492365963917331,906704-FS1-2,"177 ,   a  Sudden and marked reduction in BP following parenteral administration of PHENTOLAMINE suggests PHEOCHROMOCYTOMA;  a   however, false negative and false positive responses are frequent.",PHEOCHROMOCYTOMA,PHENTOLAMINE,RO-may_diagnose
504170045,7/17/2014 11:17:58,,1325175503,7/17/2014 11:17:16,prodege,0.6597,27934334,GBR,"","",86.130.153.15,no_relation,106,84,,121,96,treats,0.492365963917331,906704-FS1-2,"177 ,   a  Sudden and marked reduction in BP following parenteral administration of PHENTOLAMINE suggests PHEOCHROMOCYTOMA;  a   however, false negative and false positive responses are frequent.",PHEOCHROMOCYTOMA,PHENTOLAMINE,RO-may_diagnose
504170045,7/17/2014 13:10:49,,1325263927,7/17/2014 13:10:25,neodev,0.7137,21515166,NLD,11,Nootdorp,83.86.58.179,PHENTOLAMINE treats PHEOCHROMOCYTOMA,106,84,,121,96,treats,0.492365963917331,906704-FS1-2,"177 ,   a  Sudden and marked reduction in BP following parenteral administration of PHENTOLAMINE suggests PHEOCHROMOCYTOMA;  a   however, false negative and false positive responses are frequent.",PHEOCHROMOCYTOMA,PHENTOLAMINE,RO-may_diagnose
504170045,7/17/2014 13:40:42,,1325292778,7/17/2014 13:40:22,prodege,0.5202,28039757,GBR,L8,Southport,109.155.158.54,no_relation,106,84,,121,96,treats,0.492365963917331,906704-FS1-2,"177 ,   a  Sudden and marked reduction in BP following parenteral administration of PHENTOLAMINE suggests PHEOCHROMOCYTOMA;  a   however, false negative and false positive responses are frequent.",PHEOCHROMOCYTOMA,PHENTOLAMINE,RO-may_diagnose
504170045,7/17/2014 14:04:07,,1325314734,7/17/2014 14:03:48,clixsense,0.5901,15189335,GBR,T5,Aberdeen,90.218.222.164,PHENTOLAMINE treats PHEOCHROMOCYTOMA,106,84,,121,96,treats,0.492365963917331,906704-FS1-2,"177 ,   a  Sudden and marked reduction in BP following parenteral administration of PHENTOLAMINE suggests PHEOCHROMOCYTOMA;  a   however, false negative and false positive responses are frequent.",PHEOCHROMOCYTOMA,PHENTOLAMINE,RO-may_diagnose
504170045,7/17/2014 14:06:47,,1325317040,7/17/2014 14:06:29,neodev,0.5669,18339121,USA,SC,Sumter,173.93.188.194,PHENTOLAMINE treats PHEOCHROMOCYTOMA,106,84,,121,96,treats,0.492365963917331,906704-FS1-2,"177 ,   a  Sudden and marked reduction in BP following parenteral administration of PHENTOLAMINE suggests PHEOCHROMOCYTOMA;  a   however, false negative and false positive responses are frequent.",PHEOCHROMOCYTOMA,PHENTOLAMINE,RO-may_diagnose
504170045,7/17/2014 14:09:18,,1325319277,7/17/2014 14:08:53,clixsense,0.7183,27871219,NLD,07,Amsterdam,87.210.207.223,PHENTOLAMINE treats PHEOCHROMOCYTOMA,106,84,,121,96,treats,0.492365963917331,906704-FS1-2,"177 ,   a  Sudden and marked reduction in BP following parenteral administration of PHENTOLAMINE suggests PHEOCHROMOCYTOMA;  a   however, false negative and false positive responses are frequent.",PHEOCHROMOCYTOMA,PHENTOLAMINE,RO-may_diagnose
504170046,7/17/2014 10:34:50,,1325142029,7/17/2014 10:34:31,clixsense,0.8472,19162475,GBR,M3,Frome,82.33.126.30,FLAT ADENOMAS causes HIGH GRADE DYSPLASIA,90,49,,109,62,causes,0.97439119569462,901798-FS1-4,"Compared with polypoid adenomas of similar size, FLAT ADENOMAS show a higher frequency of HIGH GRADE DYSPLASIA and rapid submucosal invasion.",HIGH GRADE DYSPLASIA,FLAT ADENOMAS,RO-disease_has_finding
504170046,7/17/2014 11:23:15,,1325179294,7/17/2014 11:22:31,prodege,0.6181,15439740,AUS,02,Jannali,27.96.208.89,no_relation,90,49,,109,62,causes,0.97439119569462,901798-FS1-4,"Compared with polypoid adenomas of similar size, FLAT ADENOMAS show a higher frequency of HIGH GRADE DYSPLASIA and rapid submucosal invasion.",HIGH GRADE DYSPLASIA,FLAT ADENOMAS,RO-disease_has_finding
504170046,7/17/2014 11:56:53,,1325204663,7/17/2014 11:56:28,tremorgames,0.7111,24449707,CAN,QC,Laval,96.21.249.72,FLAT ADENOMAS causes HIGH GRADE DYSPLASIA,90,49,,109,62,causes,0.97439119569462,901798-FS1-4,"Compared with polypoid adenomas of similar size, FLAT ADENOMAS show a higher frequency of HIGH GRADE DYSPLASIA and rapid submucosal invasion.",HIGH GRADE DYSPLASIA,FLAT ADENOMAS,RO-disease_has_finding
504170046,7/17/2014 13:12:14,,1325265408,7/17/2014 13:11:33,neodev,0.7137,21515166,NLD,11,Nootdorp,83.86.58.179,FLAT ADENOMAS causes HIGH GRADE DYSPLASIA,90,49,,109,62,causes,0.97439119569462,901798-FS1-4,"Compared with polypoid adenomas of similar size, FLAT ADENOMAS show a higher frequency of HIGH GRADE DYSPLASIA and rapid submucosal invasion.",HIGH GRADE DYSPLASIA,FLAT ADENOMAS,RO-disease_has_finding
504170046,7/17/2014 13:37:34,,1325289824,7/17/2014 13:36:57,clixsense,0.6825,6574199,USA,TX,San Antonio,207.230.144.242,FLAT ADENOMAS causes HIGH GRADE DYSPLASIA,90,49,,109,62,causes,0.97439119569462,901798-FS1-4,"Compared with polypoid adenomas of similar size, FLAT ADENOMAS show a higher frequency of HIGH GRADE DYSPLASIA and rapid submucosal invasion.",HIGH GRADE DYSPLASIA,FLAT ADENOMAS,RO-disease_has_finding
504170046,7/17/2014 14:03:47,,1325314441,7/17/2014 14:03:36,clixsense,0.5901,15189335,GBR,T5,Aberdeen,90.218.222.164,HIGH GRADE DYSPLASIA causes FLAT ADENOMAS,90,49,,109,62,causes,0.97439119569462,901798-FS1-4,"Compared with polypoid adenomas of similar size, FLAT ADENOMAS show a higher frequency of HIGH GRADE DYSPLASIA and rapid submucosal invasion.",HIGH GRADE DYSPLASIA,FLAT ADENOMAS,RO-disease_has_finding
504170046,7/17/2014 14:07:07,,1325317340,7/17/2014 14:06:48,neodev,0.5669,18339121,USA,SC,Sumter,173.93.188.194,FLAT ADENOMAS causes HIGH GRADE DYSPLASIA,90,49,,109,62,causes,0.97439119569462,901798-FS1-4,"Compared with polypoid adenomas of similar size, FLAT ADENOMAS show a higher frequency of HIGH GRADE DYSPLASIA and rapid submucosal invasion.",HIGH GRADE DYSPLASIA,FLAT ADENOMAS,RO-disease_has_finding
504170047,7/17/2014 10:22:53,,1325132382,7/17/2014 10:22:44,clixsense,1.0,27793793,GBR,C5,Chester,151.230.27.155,NASAL NAFARELIN treats ENDOMETRIOSIS,141,91,,153,106,treats,0.943456353049726,907593-FS1-2,"1]  Henzl MR, Corson SL, Moghissi K, Buttram VC, Berqvist C, Jacobson J. Administration of NASAL NAFARELIN as compared with oral danazol for ENDOMETRIOSIS",ENDOMETRIOSIS,NASAL NAFARELIN,RO-may_treat
504170047,7/17/2014 11:56:27,,1325204458,7/17/2014 11:56:08,tremorgames,0.7111,24449707,CAN,QC,Laval,96.21.249.72,NASAL NAFARELIN treats ENDOMETRIOSIS,141,91,,153,106,treats,0.943456353049726,907593-FS1-2,"1]  Henzl MR, Corson SL, Moghissi K, Buttram VC, Berqvist C, Jacobson J. Administration of NASAL NAFARELIN as compared with oral danazol for ENDOMETRIOSIS",ENDOMETRIOSIS,NASAL NAFARELIN,RO-may_treat
504170047,7/17/2014 13:39:45,,1325291915,7/17/2014 13:39:28,prodege,0.5202,28039757,GBR,L8,Southport,109.155.158.54,no_relation,141,91,,153,106,treats,0.943456353049726,907593-FS1-2,"1]  Henzl MR, Corson SL, Moghissi K, Buttram VC, Berqvist C, Jacobson J. Administration of NASAL NAFARELIN as compared with oral danazol for ENDOMETRIOSIS",ENDOMETRIOSIS,NASAL NAFARELIN,RO-may_treat
504170047,7/17/2014 13:59:26,,1325310067,7/17/2014 13:58:51,clixsense,0.6744,6579377,CAN,BC,Richmond,174.6.142.227,NASAL NAFARELIN treats ENDOMETRIOSIS,141,91,,153,106,treats,0.943456353049726,907593-FS1-2,"1]  Henzl MR, Corson SL, Moghissi K, Buttram VC, Berqvist C, Jacobson J. Administration of NASAL NAFARELIN as compared with oral danazol for ENDOMETRIOSIS",ENDOMETRIOSIS,NASAL NAFARELIN,RO-may_treat
504170047,7/17/2014 14:07:07,,1325317339,7/17/2014 14:06:48,neodev,0.5669,18339121,USA,SC,Sumter,173.93.188.194,NASAL NAFARELIN treats ENDOMETRIOSIS,141,91,,153,106,treats,0.943456353049726,907593-FS1-2,"1]  Henzl MR, Corson SL, Moghissi K, Buttram VC, Berqvist C, Jacobson J. Administration of NASAL NAFARELIN as compared with oral danazol for ENDOMETRIOSIS",ENDOMETRIOSIS,NASAL NAFARELIN,RO-may_treat
504170047,7/17/2014 14:31:56,,1325339900,7/17/2014 14:31:45,clixsense,0.4918,20614047,USA,MO,Maryville,174.32.162.147,NASAL NAFARELIN treats ENDOMETRIOSIS,141,91,,153,106,treats,0.943456353049726,907593-FS1-2,"1]  Henzl MR, Corson SL, Moghissi K, Buttram VC, Berqvist C, Jacobson J. Administration of NASAL NAFARELIN as compared with oral danazol for ENDOMETRIOSIS",ENDOMETRIOSIS,NASAL NAFARELIN,RO-may_treat
504170047,7/17/2014 15:04:38,,1325369305,7/17/2014 15:04:11,elite,0.534,28276268,USA,MI,Taylor,67.149.247.166,NASAL NAFARELIN treats ENDOMETRIOSIS,141,91,,153,106,treats,0.943456353049726,907593-FS1-2,"1]  Henzl MR, Corson SL, Moghissi K, Buttram VC, Berqvist C, Jacobson J. Administration of NASAL NAFARELIN as compared with oral danazol for ENDOMETRIOSIS",ENDOMETRIOSIS,NASAL NAFARELIN,RO-may_treat
